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ABSTRACT 
Early detection of circulating biomarkers in human fluids can improve the quality of life reducing the 
development of several deadliest diseases. Among the latest and most significant medical concept 
“Liquid Biopsy” is emerging as non-invasive method of gleaning insight into the dynamics of diseases 
through a patient fluid sample. Actually many tests have been developed in this context, however, despite 
all the efforts, the majority are complex, require extensive manipulations and skilled operators, failing 
for point of care (POC) applications. 
The main focus of this thesis has been devoted to develop advanced technologies, based on a hydrogel 
platform, properly designed for biosensing application. In particular, PEG engineered hydrogel 
microparticles have been synthetized with different chemical strategies and functionalized with 
oligonucleotide probes to detect circulating biomarker in human serum. In this thesis, the parameters 
affecting the hydrogel biosensing properties have been carefully evaluated to obtain an accurate 
functionalized network capable of sensitive and specific biomarker recognition. The developed hydrogel 
assays are based on the optical fluorescence read out over a single microgel, fixed the number of 
microgels and sample volume for each test. Therefore, the target concentration is easily quantified 
comparing the fluorescence observed with a calibration curve.  
The thesis starts with the description of a microgel-based bioassay for Cytomegalovirus infection 
diagnosis (Chapter 2). The bioassay is based on microgels, with core-shell architecture, endowed with 
optical fluorescence probes for the recognition of circulating endogenous viral hcmv-miR-US4-5p. In 
particular, a double strand is used as probe and the recognition is driven by a toehold strand displacement 
mechanism whit a consequent fluorescence recovery after target capture. The performances of optical 
detection in terms of dynamic range and limit of detection are finely tuned changing the number of 
microgels per assay. As results, the limit of detection (LOD) is tuned from fM to aM by 100-fold 
decreasing the microgel concentration. The assay results specific for the selected target, suitable for 
several laboratory equipment, stable over a one-year span time and not affected by the presence of serum.  
Then, a microgel-based bioassay is described for microRNA biomarker detection in cancer application 
(Chapter 3). In this case, the outmost shell of microgel is functionalized with molecular beacons for 
circulating miR-21 recognition. The probe design is opportunely projected to reduce the interferences at 
the surface and the probe density is tuned to minimize the crowding effect. The molecular beacon-
microgels assay is resulted very sensitive reaching fM LOD in 3 hours, without preliminary amplification 
step and using only 20 µL of sample. In addition, the microgel assay is extremely specific towards single 
mutated targets (SNP). The versatility, the stability in presence of high concentrations of interfering 
oligonucleotides and capability of work in human serum make the assay very interesting for biosensing 
application.  
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Is hydrogel-based technology also suitable for long oligonucleotide sequence detection? Yes, it is, and 
in Chapter 4 are elucidated the main parameters taken into consideration to develop sensitive and specific 
microgel-based assay for long oligonucleotide detection, as lncRNA, mRNA or DNA. In particular, in 
this study are considered two DNA sequences of 111 nucleotides, with 70% of sequence similarity. Core-
shell microgels are functionalized with double strand or molecular beacon probes and their performance 
compared. Microgels functionalized with molecular beacons have achieved femtomolar LOD, high 
specificity toward the similar sequence and rapid time of analysis avoiding sample manipulation. 
Finally, is described the design of Three-dimensional hydrogel microparticles by microfluidics for the 
detection of microRNA and in particular is presented a case study of miR-143-3p detection as early 
biomarker in Amyotrophic lateral sclerosis (Chapter 5). The pivotal steps involved in the design of these 
3D hydrogels, homogeneously functionalized into their whole volume, are explained. The design of the 
immobilized DNA probes and their density are opportunely optimized. Furthermore, the diffusion into 
the polymer network is tuned adjusting the polymer concentration and consequently the characteristic 
mesh size. Once these parameters have been set, 3D-hydrogels are synthetized in microfluidics, armed 
with fluorescent probes and then mixed with the sample solution. Target detection is achieved by double 
strand displacement assay associated with a fluorescence depletion within the hydrogel microparticles. 
The optimization of synthesis parameters has allowed to obtained 3D-hydrogel microparticles with wide 
working range, pM LOD and good specificity. Moreover, due to the PEG anti-fouling property, target 
detection occurs in human serum with performance comparable to those observed in PBS buffer. 
Therefore, the biosensing platform obtained using engineered hydrogels can represent a smart 
technology capable to predict, identify and follow-up several diseases, monitoring free circulating 
oligonucleotides in body fluids. The flexible use of these engineered hydrogels, which avoid sample 
manipulation and can be easily integrated in miniaturized device for optical readout, aims to push these 
technologies as point of care device. 
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CHAPTER 1 
1. INTRODUCTION 
Many analytical methods have been developed to identify oligonucleotide biomarkers in human fluids, 
however, the majority require extensive manipulation of the sample, repeated separation and washing 
steps resulting time-consuming, expensive and subject to errors. For these reasons, in the last year many 
mix & read assays have been developed through engineered biosensors leading the way toward 
innovative devices for liquid biopsy and Point of Care (POC) applications1,2. These mix & read assays 
are easily performed by mixing the sample solution with engineered biosensors equipped by signal 
generator probes and making possible the reading of a detectable signal in solution or on solid surface.  
The work presented in this thesis aims to point out the features of this new class of engineered 
biosensors, characterized by sensitivity, specificity and capability of work directly in human fluids. 
In this chapter are briefly discussed the concerns that have led us to develop hydrogels for biosensing 
application, focusing on: 1) the appealing properties of hydrogels, the importance of the material choice 
and the strategy of target capture; 2) the methods available to synthetize hydrogels; 3) the clinical 
importance of oligonucleotides as innovative circulating biomarkers and the innovative highly 
performant biosensors based on hydrogel recently developed for oligonucleotide detection. 
 
1.1. HYDROGELS IN BIOSENSING 
In Biosensor field, hydrogel-based technologies have attracted considerable attention during the last 
years, as confirmed by the number of studies published (Figure 1). This huge interest is due to 
hydrophilic, bio-friendly and highly tunable nature of these materials, which make them very suitable in 
diagnostics3,4 and in many other biomedical fields such as drug delivery5, tissue engineering6 and 
pharmaceutical applications 7.  
Hydrogels are physically or chemically cross-linked materials able to absorb large amounts of water 
without dissolve. The capacity to absorb and store water within the polymer network makes them 
distinctive materials8. Indeed, they absorb water because of the hydrophilic nature of the functional 
groups present into the polymer backbone and, at the same time, they are resistant to dissolution since 
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the cross-links between network chains. In this way, the water within the hydrogel permits the free 
diffusion of soluble molecules, while the cross-linked network works as support.  
Moreover, hydrogels are easily synthetized with a variety of chemical strategies and functionalized with 
several biological entities such as nucleic acids or proteins. Thus, hydrogels can be engineered for capture 
and detection of clinically relevant analytes including but not limited to proteins, DNA, mRNA, and 
microRNA (miRNA)9. 
The main advantages of hydrogels in biosensing consist on their optimal environment for the 
immobilization, the enhanced molecule permeability, the reduced non-specific interactions with analytes 
that improve the sensitivity and accuracy, the encoding versatility and the enhanced thermodynamic 
constant association within the polymeric hydrogel network. However, there are still some limitations 
that reduce the clinical applications of these hydrogels. In particular, the kinetics of hybridizations are 
slower compared to free solution probes and the shelf-life of hydrogel biosensors is not well investigated 
over long period of times. Moreover, it is still necessary to develop sensitive and portable analytic device 
to ensure the readout of exact measurements.  
 
 
 
Figure 1 Histogram showing the increase in publications related to the keyword “hydrogel” “biosensor” during the past 30 years (PubMed 
data) 
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1.1.1. CLASSIFICATION OF HYDROGELS  
Hydrogels are classified based on the origin and ionic charges, the nature of swelling, the technique of 
preparation, physical properties, and nature of crosslinking (Figure 2).  
Firstly, Hydrogels can be classified into two groups based on their natural or synthetic origins10. 
Moreover, they are also divided based on the nature of side groups in neutral or ionic11. In neutral 
hydrogels, the swelling is driven by the contribution of thermodynamic mixing water-polymer, which 
contributes to the overall free energy, along with elastic polymer contribution. In ionic hydrogels, the 
swelling is also affected by the ionic interactions between charged polymers and free ions12. Therefore, 
these hydrogels, holding ionic groups (such as carboxylic acid) can absorb large amount of water because 
of their improved hydrophilicity.  
Hydrogels can be further classified based on their cross-linking chemistry. In chemically cross-linked 
hydrogel covalent bonds are present between the different polymer chains. This strong linkage is obtained 
by monomer polymerization in presence of a crosslinking agent, through several chemical strategies. 
Physically cross-linked hydrogels, instead, are based on physical interaction between polymer chains (as 
polymer chain entanglement and/or non-covalent interactions). Sometimes physically cross-linked 
hydrogels are preferred because they avoid the use of crosslinking agents, which are usually toxic and 
can affect the integrity of the molecules entrapped into the hydrogel13. However, the attractive forces 
holding these networks together are typically based on hydrogen bonding, electrostatic or hydrophobic 
interactions and gels can be reversibly dissolved under certain conditions that would weaken these 
attractive forces, i.e. a change in pH14. 
Moreover, hydrogels can be grouped based on the interaction with the external environment15. In 
particular, hydrogels can change their size or shape in response to stimuli such as the temperature, pH16,17, 
ionic strength17, light18 and electric field19. 
Finally, hydrogels can be classified based on their dimensions in microgels, microparticles and 
macrogels. Microgels have diameter included between 100 nm to 1m and are usually definite as a 
colloidal stable system. Hydrogel microparticles have a diameter ranging from 10 to 100m, while 
increasing the diameter over 100 m they are classified as macrogels.  
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Figure 2 Classification of hydrogels 
 
1.1.2. HYDROGEL MATERIALS  
Many polymers are available to synthetize hydrogels as collagen, gelatin, chitosan, hyaluronic acid, 
alginate, poly(vinyl alcohol) (PVA), poly(propylene fumarate) (PPF), PNIPAAm20, however, 
polyethylene glycols (PEGs) are the most used for diagnostic applications. The great popularity of PEG 
arises by the unique combination of physicochemical and biological properties of the polymer. These 
included the good solubility in water, the biocompatibility and the capacity to reject protein adsorption 
(antifouling)21. Moreover, PEGs are low-cost materials and they are available in several molecular 
weights and chemical modifications22. For all these appealing properties, PEGs are considered ideal 
materials to create hydrogels for biosensing applications. 
To obtain PEG hydrogels, the polymerization reaction usually occurs by free-radical polymerization 
between (meth)acrylate or diacrylates PEG derivatives in presence of a UV-sensitive photoinitiator 
(hydroxyalkylphenone specie)23. In recent years, PEG hydrogels have been successfully obtained also by 
click chemistry. This chemistry comprises a variety of specific and controllable biorthogonal reactions. 
In particular, the recent development of copper-free click chemistry such as strain-promoted azide-alkyne 
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cycloaddition, radical mediated thiol-ene chemistry, DielseAlder reaction, tetrazole-alkene photo-click 
chemistry, and oxime reaction have allowed forming hydrogels using milder reaction conditions, with 
high reactivity and selectivity24,25. 
However, in order to customize hydrogels for a specific biosensing application is necessary to fine tune 
the hydrogel microstructure. Hydrogels must be accessible to target molecules maintaining their 
structural properties. To achieve this goal, the composition of monomers and the polymerization 
conditions must be tuned to optimize the porosity, the rigidity and the swelling behavior of the hydrogel. 
As an example, in UV polymerization, increasing the concentration of photoinitiator (1-10%) and the 
exposure time hydrogels with smaller pore and higher rigidity are obtained. Contrarily, the porosity is 
augmented increasing the molecular weight of PEG precursor and lowering its concentration. However, 
longer PEG chain or lower concentration of polymer reduce the cross-linking density with a consequent 
decrease of the hydrogels rigidity26. Porosity can also be modified adding an inactive porogen27 to the 
precursor solution, that is washed away after the crosslinking. The diffusion of biomolecules is easily 
controlled in click chemistry, where the biophysical properties of the hydrogel are adjusted by altering 
the length of the PEG arms as well as the stoichiometric ratio of species involved in the biorthogonal 
reaction28. 
1.2. PROBE IMMOBILIZATION 
Hydrogels for biosensing applications can be prepared by different synthesis processes, however, they 
must be functionalized with bio-recognition elements motifs such as peptides, enzyme or 
oligonucleotides to recognize the target. There are numerous immobilization strategies depending on the 
reactive groups on the substrate and biomolecule, the type of immobilization (covalent and non-covalent) 
and on the risk for biomolecule damage during the coupling (UV exposure, free radical temperature, 
strong solvents). The immobilization is carried out by physical adsorption of the bioprobes or by covalent 
coupling. 
In physical adsorption, the immobilization of bioprobes does not require reactive chemical groups and 
is easily carried out incubating the bio-recognition elements with the substrates29 or physically entrapping 
them into the polymer mesh during the crosslinking30. In both cases, low efficiency of immobilization or 
high non-specific adsorption is often achieved.  
In covalent immobilization, bio-recognition elements are coupled on hydrogel through a covalent bond. 
In this way, a more robust control over the functionalization is obtained and leaching issues are avoided. 
Two strategies are mainly used in covalent immobilization. In the first, bioprobes are previously modified 
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with an opportune moiety and then immobilized during the polymerization process (One-step 
immobilization). In the second, bioprobes are immobilized after the polymerization step (Two-step 
immobilization). When PEG hydrogels are used as substrates, during the synthesis are usually added 
molecules with a reactive group (i.e. carboxyl group or biotin) and the bio-probes are immobilized using 
their own reactive groups or are modified with specific moieties (i.e. amino or streptavidin).  
In DNA biosensors, bio-recognition elements as double strand and molecular beacon probes are widely 
used. They are immobilized on the substrate both during the polymerization process and after the 
synthesis of hydrogels. 
 
1.2.1. DOUBLE STRAND PROBE 
The double strand probe31 is composed of two oligonucleotide sequences partially complementary that 
hybridize forming a stable duplex (figure 3A). Spontaneous dissociation of this double-stranded DNA 
probe is slow, but in presence of the target strand with higher stability, strand displacement occurs32. 
Strand displacement can be initiated at complementary single-stranded domains (referred to toeholds)33,34 
and advances through a branch migration process that is similar to a random walk (figure 3B). Indeed, in 
this process a domain displaces another of identical sequence by a series of reversible single nucleotide 
dissociation and hybridization steps35. The process of displacement is usually monitored by fluorescence 
emission fluctuation after tagging the strands with a fluorophore-quencher31 or a fret pair36.  
By changing the toehold characteristics, the rate of strand-displacement reactions can be quantitatively 
controlled. In their studies Zhang and Winfee 37 demonstrated that tuning the length and sequence of the 
toehold domain the kinetics of strand displacement can be accurately modeled and predicted.  
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Figure 3 Double strand toehold mediated displacement assay. A) double strand probe structure. B) mechanism of displacement mediated 
by toehold domains; C) Strand displacement rate constant plotted against toehold length and composition (A/C Reprinted from Nat. Chem 
2011 reference 38;-Reprinted from J. Am. Chem. Soc. 2009 ref 37;). 
In particular, they have simplified the kinetics model of toehold strand displacement to a simple 
bimolecular reaction with second-order rate constants: 
𝑋 (𝑚, 𝑛) +   𝑆 
𝑘(𝛽𝑚,𝛽𝑚,𝛾𝑛)
→        
𝑘(𝛾𝑛,𝛽𝑚,𝛽𝑚) 
←        𝑌 + 𝐿 (𝑚, 𝑛) 
The associated forward and reverse second-order rate constants k(β
m
, βm, γ
n
) and k(γ
n
, βm, β
m
) for this 
bimolecular reaction model (BM) of strand displacement are dependent on the sequences of the βm,βm, 
and γn domains (figure 3B), as well as the ambient temperature and salt concentrations37. 
In particular, they have shown that the rate constant of the strand displacement reaction can vary over 
a factor of 106, from 1 M–1 s–1 to 6 × 106 M–1 s–1 and that the GC composition of the toehold strand affects 
the kinetics rate of the displacement process. As shown in Figure 3C, toehold composed of only G/C 
nucleotides (green line) has faster kinetics compared to toehold composed of roughly equal numbers of 
all four nucleotides, while toehold composed only of A/T nucleotides (red line) are the slowest. The grey 
region spanned by the green and red traces roughly shows the range of potential kinetics based on toehold 
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length. Based on this consideration is possible to fine engineering control over the kinetics of synthetic 
DNA devices39. 
The double strand probe can be also immobilized on solid surfaces. The hybridization between the 
probe and the target is converted by the transducer in an optical, electrochemical piezoelectric or thermal 
quantifiable signal.  
In particular, microchips and microparticles have been functionalized with double strand probes for 
biosensing applications40,41. The density of immobilized capture probes and the equilibrium dissociation 
constants are calculated through a bimolecular, all-or-none model for hybridization of non-self-
complementary sequences by Stevens et al,42. They have found that for an oligonucleotide of 22 mer, 
immobilized on paramagnetic particles (diameter 0.75 µm) the Kd value is in nM order and at higher 
temperatures hybridization on particles is more efficient than in solution. 
 
Figure 4 Constant dissociation Kd predicted from solution-phase thermodynamic parameters(lines) compared with those determined 
experimentally (empty circle) (Reprinted from Nucleic Acid Research, 1999, reference 42) 
 
Oligonucleotide probes are also introduced during the polymerization reaction through a UV-
polymerizable methacrylamide linker (Acrydite™). The incorporation of this group allows engineering 
various hydrogels reducing the time of synthesis. However, Pregibon et al43 have proved that the 
efficiency of immobilization of these probes is affected by the amount of reactive species in precursor 
solutions (their efficiency of immobilization is estimated about ∼5% to 25%). To improve the efficiency 
of immobilization, they have also suggested to use acrylate probes instead of methacrylate as is known 
that acrylates react faster than methacrylates43.  
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Once the oligonucleotide-methacrylate probe is immobilized, it can hybridize with the partially 
complementary probe forming the double strand probe, otherwise, it can directly hybridize with the target 
sequence. In the latter, the hybridization is converted in an optical, electrochemical or piezoelectric or 
thermal quantifiable signal. 
 
Figure 5 Acridyte™ group attached to oligonucleotide 
 
1.2.2. MOLECULAR BEACON 
Molecular beacons have been firstly introduced by Tyagi and Kramer more than 20 years ago44. 
Essentially, a molecular beacon is a single strand oligonucleotide sequence containing a fluorophore and 
a quencher in its opposite ends. It is composed by a target recognition sequence (loop) flanked by two 
self-complementary terminal arms (stem)45,46. Because of its sequence, in absence of target the two arms 
hybridize through a mono-molecular reaction forming a stem-loop structure. In such conformation the 
fluorophore and quencher are in close proximity with a consequent quenching of the fluorescence47. 
When the DNA or RNA target is present, hybridization between the target and the loop sequence of the 
molecular beacon takes place and the stronger intermolecular hybridization mechanically forces the 
weaker stem helix to open. Thus, the fluorophore and quencher are spatially separated and fluorescence 
is restored. Molecular beacons are widely used as oligonucleotide probes due to the higher 
thermodynamic stability of the hairpin structure, the efficient signal switching and the numerous reporter 
dyes available. These aspects allow reaching excellent sensitivity and selectivity, and real-time detection 
capability. 
The design of this probe seems easy but is in reality quite sophisticated. Many studies have been focused 
on the practical rules to design molecular beacons48–51. Briefly, two are the main key factors which 
determine the characteristics and functionality of the molecular beacon: the probe structure and 
fluorescence signal switching. As regards the first, the specificity and sensitivity of molecular beacon for 
its target can be optimized by adjusting the probe length and the GC content. As general rules, the probe 
sequence has length comprised between 15-30 bases and is free from secondary structure. The stems are 
5-7 base pair and have high GC content (75-100%). Shorter stem results faster hybridization, but suffers 
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from lower signal-to-background ratio52,53. Longer stems are particularly suitable for single mismatch 
detection, however, they have slower kinetics. The fluorescence signal switching is mainly based on 
dynamic or static fluorescence quenching. Many fluorophores and quenchers existing and they must be 
carefully selected54.  
 
Figure 6 Phase transitions of molecular beacons with targets in solution. Phase 1: fluorescent molecular beacon–target duplex; phase 2: 
nonfluorescent stem–loop hairpin; and phase 3: fluorescent random coil (Reprinted from Springer. 2013, reference 51) 
 
Molecular beacons can exist at least in three distinct states: molecular beacon–target duplex (phase 1), 
stem–loop hairpin (phase 2), and random coil (phase 3). The thermodynamic and the kinetics of these 
probes have been extensively studied by Bonnet55 and Tsourkas56. In particular, they have studied the 
dissociation constants of the transition monitoring the melting curve of molecular beacons in presence 
and absence of the target. The dissociation constant K2–3 corresponding to the transition between stem–
loop hairpin and random coil is given by:  
 
𝐾2−3 (𝜃) = ( 
𝐹 − 𝛽
𝛾 − 𝐹
 ) 
where F is the fluorescence intensity at a given temperature θ, β is the fluorescence of molecular beacons 
in the hairpin form (obtained at low temperatures, such as 10°C), and γ is the fluorescence of molecular 
beacons in the random-coil form (obtained at high temperatures, such as 80°C) in the absence of targets. 
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The dissociation constant K1–2 describing the transition between molecular beacon–target duplex and the 
stem–loop hairpin can be calculated from the fluorescence data obtained by the melting measurements 
of molecular beacons in presence of the target: 
𝐾1−2(𝑇) =  
(𝛼 − 𝐹)𝑇0
(𝐹 − 𝛽) + ( 𝐹 − 𝛾 ) 𝐾2−3
 
where α is the fluorescence intensity of molecular beacon–target duplex at low temperatures such as 
10°C. 
Their studies have demonstrated that the stem length of a molecular beacon has a greater effect on its 
equilibrium state than the loop length, and that a target with single-base mismatches exhibit a less 
favorable binding with molecular beacons. They have also demonstrated that a mismatch positioned in 
the center of the probe has a greater impact on equilibrium than a terminal mismatch. Furthermore, Chen 
et al57 have proposed a three-step model to explain the molecular beacon kinetics in solution. They have 
proved that the first and second step (respectively the formation of few transient base pairs called nucleus 
and the opening of the stem with more base pairs between probe and target) are the rate-limiting steps, 
while the third step (complete hybridization between the probe and probe) is much faster. 
Due to their excellent properties, molecular beacons have found many applications in biosensing for 
the detection of several molecules of interest58–65 both in solution and immobilized on solid support. They 
are usually coupled by two step immobilization on a variety of supports as glass surfaces, on graphene, 
gold particles on optical fiber, however, despite all the efforts made, when molecular beacons are 
immobilized on solid surface the fluorescence background usually increases due to non-specific 
oligonucleotide-surface interaction and crowding effects66 among the immobilized oligonucleotide 
probes. However, these issues are avoided immobilizing molecular beacons into materials with solution-
like property. Recently, Dai et al and Ma et al67 have proved that when molecular beacons (modified with 
a biotin) are used to functionalize surface-patterned poly(ethylene glycol) hydrogels (endowed with 
streptavidin), fluorescence background strongly decreased.  
 
1.3. HYDROGEL CHARACTERISTICS FOR BIOSENSING  
Many biosensors have been developed immobilizing oligonucleotide probes on solid surface, as in 
graphic-2D layered-68, magnetic particles69–71, particles9,72–75, carbon nanomaterias76 and 
microarrays77,78. These biosensors allow high-throughput analysis and parallel screening of several 
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molecules of interest79, however, they suffer of some limitations80, which affect the sensitivity, the 
specificity and the kinetics of detection. In particular, they are ascribable to the electrostatic repulsion 
between probe-probe81,82, the steric hindrance between probe-target complex83,84 and the non-specific 
adsorption85 on solid substrates. Moreover, the design of the probes86–89 and the different immobilization 
methods generate slower kinetics of hybridization and inhomogeneous signal distribution90. Hydrogels 
with their tridimensional polymer network can improve these issues, however, during the design of 
hydrogel-based assay a number of concerns must be taken into consideration. In particular, the swelling 
behavior of the hydrogel, the probe density and the molecules diffusion affect the sensitivity of the assay. 
Firstly, the hydrogel structure at the molecular level must be optimized in order to enhance the 
hybridization between target molecules and immobilized probes, preserving the structural integrity of 
the hydrogel matrix. To achieve this goal, the monomer composition, the porosity, the rigidity and the 
swelling behavior of the hydrogel must be tuned. Concerning the porosity and the swelling behavior, it 
is possible to control these parameters by adjusting the starting material properties as the monomer 
concentration, the mass weight and the amount of cross-linker. For biosensing application, it is desirable 
that the diffusion and the target capture are not hindered by the biological fluids composition. For these 
reasons, hydrogels are opportunely engineered in order to preserve porosity, chemical background, and, 
therefore, the target diffusion. 
The network structure of a hydrogel is characterized by the determination of the polymer fraction (v2, 
s), the molecular weight of the polymer chain between two neighboring cross-linking points (Mc) and 
the correlation distance between them, also known as mesh size (ξ). The nature and the amount of 
polymer fraction define how a hydrogel is capable to imbibe and retain water, while the Mc and ξ are 
averaged parameters that define the accessibility and the transport of molecular species in the network40. 
However, all these parameters are described theoretically by the equilibrium swelling theory and the 
rubber elasticity, while a variety of techniques are available to experimentally measure and verify them91. 
The structural characterization of hydrogels is usually carried out on bulk, calculating the degree of 
hydration (swelling measurements) by weighting the amount of water up-taken by the polymer and 
converting it in the volumetric fraction according to the “equilibrium swelling theory” developed by 
Flory and Rehner92 and then modified by Peppas and Merrill93,94. Swelling on hydrogel particles has been 
experimentally measured by few groups. Lee et al95 have proved that the swelling on shape-encoded 
particles increases using PEGDA precursor with higher molecular weight, but the particle shape is 
isotropic. Recently, Battista et al96 have demonstrated the direct determination of swelling on core/shell 
microgels responsive to pH, through atomic force microscopy (AFM) analysis. 
15 
 
 
Figure 7 Swelling of hydrogel PEGDA microparticles synthetized with different molecular weight of starting monomer (Reprinted from 
Biomed. Microdevices, 2008, reference 95) 
 
Another important parameter to take into account is the probe density. Differently from solid surfaces 
as microarray or polystyrene beads, hydrogels possess higher capacity of probe immobilization due to 
their tridimensional structure and increased surface area. As results, if first-order Langmuir kinetics is 
assumed, increasing the probes density more target/probe complex are formed at equilibrium with a 
consequently improved sensitivity. Comparing glass surfaces and hydrogel pads for microchips 
development, Srinivas et al97 and Zubstov et al98 have demonstrated that three-dimensional gel networks 
possess higher capacity for immobilization. They have proved that in surface-based systems the steric 
hindrance is a limitation with only ∼104 molecules/μm2 immobilized and increasing the amount of probe 
the immobilization efficiency is not improved. In contrast, hydrogel substrates allow immobilizing ∼105 
molecules/μm2 (calculated on 10 μM of probe concentration and hydrogel height of 35 μm) achieving 
effective surface density at least 1 order of magnitude greater than glass surface. Furthermore, when solid 
surfaces are functionalized at maximum capability, the proximity between probes can decrease the target 
accessibility reducing the assay sensitivity. Otherwise, hydrogels allow immobilizing high amount of 
probes keeping enough distance between them, hence target is free to diffuse and hybridize with the 
probe98. 
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Finally, the target diffusion within the polymer matrix must be considered. The structural parameters 
of hydrogels must be appropriately tuned to promote the diffusion of the target and improve the 
probe/target complex formation, thus the sensitivity of the detection. This because if the target is bigger 
than the mesh size of the polymer its diffusion is hindered or is very low. Contrary, if the polymer is too 
porous, fewer probes are immobilized during its functionalization, affecting the assay sensitivity. 
In free solution and in absence of any interactions with other target biomolecules, the diffusion process 
is governed by Stokes-Einstein relation: 
𝐷0 =
𝑘𝐵𝑇
(6𝜋𝑅ℎ)
 
where kB is the Boltzmann constant, T is the temperature in kelvin,  is the solvent viscosity and Rh is 
the hydrodynamic radius of the target. In hydrogels, the diffusion is described by different models, based 
on the nature of the biomolecule target. 
For oligonucleotide with Rg < a/2, where Rg is the gyration radius of the molecules and a is the mean 
gel pore size, the diffusion coefficient is calculated by the Zimm99 model: 
𝐷0 =
0.196𝑘𝐵𝑇
(𝑅ℎ)
≈  𝑁0
−1
2⁄  
When Rg > a/2, the movement of an unattached chain by Brownian motion into the multi-chain system 
forming by the hydrogel is described by the reputation theory. The lateral movement of the chain is 
limited by gel fibers with a resulting loss of entropy that brings the chain to migrate inside a tube with 
length L = Na, where N is the number of pores occupied by the chain. In this condition: 
𝐷0 =
𝑘𝐵𝑇 𝑎
2
(3 𝑁𝑘
2 𝜁𝑘𝑏2)
 ≈ 𝑁0
−1
2⁄  
a represents the pore size, NK is the number of Kuhn segments 𝜁K is the friction coefficient of a Kuhn 
segments, and b is the Kuhn length. 
In this context, target diffusion and probe/target hybridization are widely studied and modeled in 
hydrogels. Sorokin et al100 focused on the kinetics of oligonucleotides on microchips using hydrogel pads 
and have compared their performance with glass surfaces. They define the hybridization time as: 
𝜏𝑑𝑖𝑓𝑓
(𝐻)
=
𝑅?̃?𝐾𝑎
𝛽 𝐷𝑠𝑜𝑙(1 + 𝐾𝑎ℎ𝑠𝑜𝑙)
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Where R is radius of microbeads, ?̃? is the probe density for unit area, Ka is the association constant, β 
is a numerical factor and is equal to unity for hybridization on the microbeads, Dsol is diffusion 
coefficient for target DNA in solution, hsol is the homogenous concentration of target in solution. 
They have demonstrated that although hydrogels show slower kinetics due to hinder diffusion of analytes 
within the mesh, the sensitivity at equilibrium and the capability to detect mismatch are increased 
compared to solid surfaces. This is explained as results of the better thermodynamic association constants 
within the hydrogel, that appears closer to the ideal solution because of the high water content and the 
sufficient space between probe molecules despite a higher effective probe density. 
Diffusion studies have been carried out by Pregibon and Doyle43 using a three-dimensional hydrogel 
array. They have considered a system where target oligonucleotides (Ts in solution and T within the 
particles) diffuse into the hydrogel and hybridize with probes P to form complexes TP. Considering that 
the rules governing this transport are complex, nonlinear and coupled, they have assumed that in a 
specific regime, which is relevant for most assays, the system can be simplified to a one-dimension 
problem. Scaling arguments can be made to reduce the complexity of this problem. In this way, they are 
able to calculate:  
(1) the ratio of target to probe molecules γ: 
𝛾 =
[𝑇𝑠]0𝑉𝑠
([𝑃]0 𝑁𝑝𝑉𝑝)
 
where [Ts]0 and [P]0 are respectively the concentration of target and probe at t = 0, Vs is the sample 
volume, Np is the number of particle and Vp is the volume of the particle; 
(2) the rate of association versus diffusion which is given by the Damköhler number Da  
𝐷𝑎 =
𝐾𝑎[𝑃]0
(𝐷𝑔𝑒𝑙 𝐿2)⁄
 
where ka is the second-order association rate constants, Dgel is the target diffusivity and L is the 
characteristic length for the diffusion path, and  
(3) the relative strength of hybridization κ: 
κ =
𝐾𝑑
[𝑇𝑠]0
 
where Kd is the first-order dissociation constant. 
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In the study they have shown that for short oligonucleotide (20bp) ka (10
6 M-1s-1) is much higher than 
D (10-11 m2/s), therefore Da >> 1, if [P]0 is about 10
-6 M and L around 10-6 m; even at low amount (<10-
18 mol) the probe can be considered in large excess, therefore  << 1, while hybridization is very strong 
at initial target concentration (<< 1) if considering Kd in the order of 10-13 M and [Ts]0 around 10-11 M. 
In the case of larger oligonucleotide101, ka is around 10
3 M-1s-1, while assuming that D is the same of 
other biomolecules with the same Rg (10-8–10-10 m2/s), Da can be in the unity range if [P]0 is about 10-6 
M and L around 10-6 m; the probe can be considered in large excess even at low amount, therefore  <<1. 
The study has also shown that the 3Dgel array is mass-transport limited since reaction occurs 
significantly faster than diffusion throughout the gel (Da>>1). These properties can reduce the target 
diffusion into the hydrogel with a consequent confinement of the signal at the outer edge of the hydrogel 
particles at low target concentrations. 
To sum up, to design sensitive and specific assay based on functionalized hydrogel is very important to 
tune the polymer/probe composition in order to: avoid swelling effect in biological fluids; have high 
probe density but, at the same time, permit free diffusion of the target; and guarantee structural stability 
during the assay. 
 
2. SYNTHESIS OF HYDROGELS 
Hydrogels for sensing purpose must be synthetized with finely controlled size, shape and encoding in 
order to satisfy the bioassay necessity. One of the major advantages of use hydrogels is the multitude of 
chemical strategies available to synthesize them. These comprise one-step procedures like 
polymerization and parallel crosslinking of multifunctional monomers, as well as multiple step 
procedures, concerning synthesis of polymer molecules with reactive groups and their subsequent 
crosslinking  
Microgels are synthetized starting from monofunctional monomers, from polymers or from macrogels. 
Their synthesis is essentially summarized in three categories based on the particle formation mechanism: 
homogeneous nucleation, emulsification and complexation.  
In the first case, a solution of soluble monomer, including a cross-linking agent, is carried out and 
microgel particles form over the course of polymerization102. To obtain good control over the particle 
formation, the polymer obtained during the polymerization must be insoluble in solution or will form a 
macrogel. The homogeneous nucleation includes emulsion polymerization (EP), surfactant-free 
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emulsion polymerization (SEP), and microgel formation from a dilute polymer solution. In the first step 
of emulsion polymerization (EP), the monomer is present as a suspension mixed with a surfactant and a 
water-soluble free radical initiator, in the second step, the polymer is polymerized into a surfactant-
stabilized microgel103. Emulsion polymerization is a robust method to obtain core-shell microgels. The 
core particles are firstly prepared by conventional emulsion polymerization and then are used as seeds 
for the second-stage shell polymerization104. This method gives core-shell particles monodisperse, as all 
oligomers formed in solution attached on pre-formed core particles, however, to avoid heteronucleation 
is important to control parameters such as the concentration of the core, initiator, surfactant and the shell 
monomer. In surfactant-free emulsion polymerization (SEP) starting from an unstable not colloidal 
precursor, particles aggregate to form new primary particles, then at the end of nucleation stage, all new 
precursor particles are captured by existing stable particles105. Moreover, microgels can be prepared by 
mixing two dilute water-soluble polymers that form complexes in water. 
The second method is emulsification. In this case, an aqueous pregel solution (a monomer or a polymer) 
is suspended in an oil phase to give a water-in-oil emulsion. In the second gelation step, the emulsion 
droplets undergo a chemical reaction to gel each emulsion droplet106. 
The last method involves dilute solutions of oppositely charged polyelectrolytes to form colloidal 
dispersed, polyelectrolyte complexes107. 
However, these conventional techniques have some limitations due to the biomolecules 
incompatibility towards organic solvent or polymerization conditions. In addition, the low 
monodispersity and the need of codes for multiplex application have led to the development of new 
techniques to synthetize hydrogels.  
Recently, microfluidics methods are arising in order to achieve major control on size and shape of 
microgels, to use milder chemistry and reduce time and cost of the synthesis. Among these, droplet 
generation based methods and flow lithography are the most used. The first method is competent for 
producing spherical or sphere-like particles, while the second is an ideal alternative for designing non-
spherical particles, such as rods and flakes, which are more desirable in some particular applications. 
Microfluidic assisted methods rely on the formation of a stable emulsion between two immiscible 
fluids as an oil phase (continuous phase) and a water phase (disperse phase). The synthesis occurs in a 
miniaturized device made of glass o polydimethylsiloxane (PDMS). The Disperse phase is usually 
composed by a water solution of monomer, biomolecules and cross-linker, while, for the continuous oil 
phase is used mineral oil, silicone oil, corn oil, hexadecane and fluorinated oil108. Additionally, a 
surfactant is added to prevent that droplets rapidly coalesce inside the devices109. The crosslinking of 
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polymeric monomers is achieved into the device (on-chip) or in separated vials (off-chip) and is induced 
by UV/Vis light110, via thiol-Michael addition click reaction111, or changing the temperature and ionic 
crosslinking112. As an example, PEG hydrogel microparticles have been widely synthetized by cross-
linking of acrylate and methacrylate monomers in microfluidic113. The polymerization is carried out 
shining UV/Vis light on the solution in presence of specific photoinitiator based on hydroxyalkylphenone 
species (i.e., Darocur, Irgacure). The homolytic scission of C–C bonds generates a benzoyl free radical 
that allows the cross-links formation in the gel. Varying the parameters as the concentration of the 
photoinitiators, the intensity of light and the exposure time is possible to tune the mechanical rigidity and 
the pores of hydrogels.  
Droplet generation is described as continuous on-chip production of water-in-oil emulsions based on 
the breakoff of droplets in two-phases at T-junction or in flow-focusing geometries. The formation of the 
droplet depends by several variabilities such as flow rates, viscosity of the fluid, dimensions of the 
geometry, capillary number (Ca) and the surface tension114. To obtain a stable emulsion and thus 
monodisperse droplets the optimal synthesis condition must be optimized. Moreover, in addition to the 
abovementioned other device geometries have been developed as micro-nozzle cross-flow system and 
co-axial capillaries115. Microfluidic droplet generation permits large production of monodisperse 
microparticles (105 per hours) spectrally or graphically encoded. 
Doyle’s group have introduced the Flow-lithography116 in 2006. In this technique particles are 
synthetized in a PDMS microfluidic device, with high throughput (18,000 particles per second). The 
shape and size of the particles are controlled using a transparency mask, which shades the UV light beam 
used to photo-cure the co-flowing laminar streams in microfluidic channels. As results, they are able to 
obtain a high number codes combining graphical and spectral encoding, as well as differential chemistries 
are possible such as Janus particles117. 
Further improvements have been made developing the stop-flow lithography118, where the pumping 
system is actuated so that the flow is stopped for few milliseconds allowing the polymerization through 
a mask. In such a way Doyle’s group have obtained particles with graphical and spectral encoding as 
well as with multiple capture probes positioned in different regions.  
Another great advantage of using hydrogel microparticle relies on the flexibility of manipulation. Assays 
based on hydrogel can be carried out in microtubes (50-500 L), microplates for higher throughput (50-
500 L) or in microfluidic devices (<10 L). Microparticles are washed and separated from the sample 
by centrifugation or, if magnetic microbeads are added during the polymerization, applying a magnetic 
field. The code reading and/or target quantification are usually measured by optical detection methods. 
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In particular, imaging methods as transmission, reflection and fluorescence microscopy or flow 
cytometry techniques are the most used. 
 
 
 
3. BIOMARKERS DESCRIPTION AND DETECTION BY 
HYDROGELS 
A biomarker is a distinctive that can be objectively measured and evaluated as an indicator of a 
physiological as well as a pathological state119. Biomarkers include nucleic acids, proteins, metabolites, 
small molecules that can specifically and sensitively reflect a disease state. For this reason, they are 
suitable for diagnosis, prognosis as well as for disease monitoring during and following therapy.  
Looking at figure 9 is clear the importance of biomarkers. They occupy a key role and are fundamental 
for personalized medicine development. Furthermore, the presence of these biomolecules free to circulate 
in biological fluid represents a non-invasive and specific way to diagnose diseases and tailor the therapy 
Figure 8 Hydrogel particles. A) Core–shell microgels obtained by free-radical polymerization and seeded polymerization 
(Reprinted by J. Am. Chem. Soc., 2015, reference 41; B) Hydrogel microparticles obtained by droplet generation; C) Flow-
focusing microfluidic droplet generation device (Reprinted from Colloids Surf B Biointerfaces, 2016, reference 113); E) 
Microparticles synthetized by stop-flow lithography technique (Reprinted from Nat. Mater, 2006, 116); F) Janus particles by 
stop-flow lithography (Reprinted from Appl. Mater. Today, 2017, reference 117); F) Stop flow lithography mechanism 
(Reprinted from Nat. Mater, 2006, 116) 
22 
 
Figure 9 Relation of biomarkers to other technologies and health care (Reprinted from Springer, 2010, reference 120) 
 
on the single individual, based on its predicted response. In this way inadequate and risky therapies are 
avoided improving the quality of life. 
Moreover, current diagnostic techniques are often based on invasive, expensive and time-spending 
methods. In addition, these techniques are often affected by low specificity or can produce false results. 
Thus, circulating biomarker detection combined with sensitive biosensing technologies can promise 
more effective diagnostics, prognostics, and monitoring approaches for a wide range of clinical settings. 
In particular, we focus on the development of hydrogel-based technologies to detect already validated 
circulating oligonucleotide biomarkers. Circulating nucleic acids have been described for the first time 
in 1948 by Mandel and Métas121. However, only at beginning of 90s their importance has been 
elucidated122. They can be separated based on their nature in circulating DNA and RNA biomarkers.  
High levels of circulating DNA can be measured in physiological conditions or clinical states, such as 
exercise123, infection124 acute trauma125, cerebral infarction126 transplantation127, and during 
pregnancy128. Furthermore, many studies have focused on the importance of circulating DNA in cancer  
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Figure 10 Circulating DNA is released in the serum of cancer patient by apoptosis, necrosis or secretion from the cancer cells. 
The DNAs circulating in human fluids have different size and is affected by mutation, methylation or alterations. Moreover, 
viral DNA is also detectable in some tumour caused by virus such as human papillomavirus (HPV), hepatitis B virus (HBV) 
and Epstein–Barr virus (EBV) (Reprinted from Nat Rev Cancer, 2011, 136). 
 
fields129–132. It has been hypothesized that circulating DNAs are produced via the release of nucleic acids 
during the apoptosis or necrosis of cancer cells or from tumour-derived exosomes133.  
Their size varies between small fragments of 70 to 200 base pairs and large fragments of about 21 
kilobases134. Furthermore, in human fluids is possible to find both mitochondrial DNA (mtDNA)135 and 
genomic DNA(gDNA). The latter includes coding and noncoding gDNA that can be used to examine 
microsatellite instability, loss of heterozygosity (LOH) 137, mutations138, polymorphisms, methylation139 
and integrity140 (size).  
Circulating RNA are also detectable in human fluids. In particular, protein-coding messenger RNAs 
(mRNA), miRNAs, piRNAs, tRNAs and miscellaneous other non-coding RNA molecules are packed in 
extracellular vesicles and are released in fluids141. These RNAs are very stable and may serve as 
biomarkers since some of them have been associated with several diseases142,143 The use of circulating 
RNAs in human fluids to detect and monitor diseases is rapidly growing. Therefore, the US National 
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Centre for Advancing Translational Sciences (NCATS) has recently launched the Extracellular RNA 
Communication Consortium to boost the use of circulating RNA in clinical applications tool144. 
MicroRNAs are small (20-25nt)145, non-coding oligonucleotides that regulate gene expression acting 
at post-transcriptional levels 146-147. They are involved in a wide range of biological processes148–156 and 
due to their immense regulatory power, variation of microRNA levels can be utilized as potential 
biomarkers for the diagnosis and prognosis of a variety of diseases including viral infections, cancer and 
neurodegenerative diseases157–164. A comprehensive curated database of miRNA and other non-coding 
RNA biomarkers is available at http://mirandola.iit.cnr.it/. However, despite the encouraging results 
observed, little progress has been achieved in terms of producing effective biomarkers for the clinic 
application.  
Protein-coding messenger RNAs (mRNA) have an essential role in numerous biological processes. 
Circulating fetal mRNAs in maternal plasma have been associated with prenatal defects165,166. Circulating 
mRNAs containing tumour-associated genetic alterations have been first validated in the 1990s in the 
plasma of patients with nasopharyngeal carcinoma167. Then the study has been extended to many other 
types of cancer and has been found that mRNAs can serve as a non-invasive biomarker in several cancers 
including breast, colorectal, lung and prostate cancer168. Moreover, circulating mRNAs have been 
associated with the progression169 of the disease as well as to the therapies response170.  
Actually, the gold standard techniques to detect free circulating oligonucleotides rely on polymerase 
chain reaction PCR, qRT-PCR171 and digital PCR172,173, which offer enhanced sensitivity and specificity. 
but require complex, expensive, time-consuming and hard-working procedures. Recently, next-
generation sequencing (NGS)174,175 has emerged as an alternative option with greater dynamic range of 
detection, increased sensitivity and reproducibility. However, these techniques have critical limitations 
due to the pre-analytical steps, such as the collection of biofluids (e.g., blood, serum, plasma), the storage 
conditions, the extraction, purification, amplification and calibration steps often source of biases that can 
compromise the assay accuracy176,177. For these reasons, novel detection systems capable of direct and 
absolute quantification of oligonucleotides in body fluids are particularly required. In addition, these 
technologies must meet the requirements of sensibility and specificity needed in biosensing such as the 
improved LOD, single mutation specificity, low cost and rapid time of analysis. 
In this context hydrogels are particularly successful. Kim et al178 have recently developed a microfluidic 
platform that immobilizes hydrogel microparticles at defined locations and encapsulates particles in 
monodisperse droplets for the detection of a panel of microRNA with diagnostic value for prostate cancer 
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and triple negative breast cancer (let-7a, miR145, and miR221). They have achieved 0.1 amol sensitivity 
(employing an enzyme amplification method) in 4hr 30 min.  
He et al,179 have realized a switchable DNA hydrogel SERS (Surface enhancement Raman spectrum) 
platform for the detection of miR-155. They have used a Duplex-specific nuclease (DSN) as enzyme 
amplification strategy achieving 0.083 fM sensitivity, single nucleotide specificity and working directly 
in human serum.  
Aliberti et al40 have developed a multiplex specific oligonucleotide detection method to detect viral 
infections. They have used spectrally encoded microgels to detect viral cDNAs, reaching limit of 
detection in the rage of 0.1–0.9 nM and avoiding previous amplification steps.  
Three different protein-coding messenger RNAs are detected by Choi et al,27 by the means of hydrogel 
microparticles in multiplex. They have tuned the mesh of PEG polymer in order to permit the diffusion 
of mRNAs achieving amol limit of detection (employing an enzyme amplification method). 
Ribosomal RNA sequences are detected by Ma et al,180 coupling a NASBA amplification with a 
microgel-tethered molecular-beacon microarray. Their technology has allowed detecting 1 fM of 
amplicons in 75 minutes.  
Additional hydrogel based bioassays recently developed to detect oligonucleotides are summarized in 
table 1. 
 
Table 1 Hydrogel based bioassays for Nucleic acid detection 
Target Material Probe Detection Sensitivity and 
multiplexing 
Code Reference 
mRNA PEGDA Oligonucleotide 
(covalent) 
capture extender, 
label extender, 
fluorescence readout 
6 amol 
3-plex 
Graphical 27 
microRNA 
oligonucleotide 
PEGDA Oligonucleotide 
(covalent) 
Displacement assay microRNA: fM 
oligonucleotide:pM 
3-plex assay 
Optical 40, 41 
20–200 nt, 
microRNAs 
PEGDA Oligonucleotide 
(covalent) 
Labeled targets or 
labeling with SAPE 
20–200nt: subattomole 
miRNA: 1 amol 
Graphical 43 
microRNA PEGDA Oligonucleotide 
(covalent) 
Universal labeling; 
Enzymatic 
amplification; 
fluorescence readout 
0.1 amol 
3-plex 
Graphical 178 
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Target Material Probe Detection Sensitivity and 
multiplexing 
Code Reference 
oligonucleotide PEGDA Oligonucleotide 
(covalent) 
NASBA; 
Fluorescence readout 
1 fM 
3-plex 
Spatial 180 
21nt o PEGDA + 
polyacrylamide 
Oligonucleotide 
(covalent) 
Complementary DNA 0.66 pM Optical 181 
microRNA PEGDA Oligonucleotide 
(covalent) 
Universal labeling 
(T4 DNA ligase); 
rolling circle 
amplification; 
fluorescence readout 
Amol 
12-plex assay 
Graphical 182 
microRNA PEGDA Oligonucleotide 
(covalent) 
Enzymatic 
amplification; 
Fluorescence readout 
10 pg/µL 
5-plex 
Spatial 183 
microRNA Polyacrylamide Oligonucleotide 
(covalent) 
Complementary DNA 1 pM - 184 
 
4. AIM AND OUTLINE OF DISSERTATION  
Since the first demonstration that hydrogels are innovative substrates to developing biosensors, many 
progress has been made in the field. This growing interest has driven us to develop biosensors based on 
hydrogel particles and, herein, some potential applications are described for the ultrasensitive detection 
of oligonucleotide biomarkers in human serum. 
Although different devices have shown great potential and some of them are already available on the 
market, there is still the necessity of new platform, capable of detect biomarkers in human fluids with 
improved sensibility and specificity, avoiding amplification steps. In order to achieve this goal, we have 
been focusing on the research of appropriate materials, which combine biocompatibility and antifouling 
properties, and on the design of specific probes. Thus, PEG-hydrogel particles have been developed and 
in order to find the best condition for biosensing application both the structural properties of the hydrogel 
and the probes density have been tuned.  
Our hydrogel-based biosensors allow overcoming the limitations of conventional techniques since 
manipulation of the sample is avoided. The detection is based on fluorescence optical readout and can be 
carried out in several common laboratory equipment.  
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In Chapter 2 microgels with core-shell structure are endowed with double strand probes to detect the 
presence of endogenous viral microRNA. The biosensing performances of these microgels are 
investigated highlighting their properties. In particular, the sensitivity scalable with the number of 
microgels, the versatility and the antifouling properties of microgels are elucidated. The assay developed 
represents an innovative way to detect Human Cytomegalovirus infection. Moreover, the assay allows 
overcoming the necessity of miRNA panels or threshold levels, whereas the endogenous hcmv-miR-US-
4 is specifically synthetized and released in human serum by the virus.  
In Chapter 3 microgels with core-shell structure are engineered with molecular beacon for microRNA 
detection. The reduce time of analysis, the specificity towards single nucleotide mutated target, as well 
as the enhanced sensitivity, scalable sensitivity and versatility represent a significant improvement of the 
biosensing technology based on microgels. In particular, a microgel-based biosensor for miR-21 
detection in cancer application is described as case study. 
In Chapter 4 a study to test the microgels assay performance in long similar oligonucleotides target 
detection is carried out. The assay is set-up using double strand and molecular beacon immobilized 
probes. This work has allowed defining the assay design guideline in order to develop high sensitive and 
specific microgels, also toward complex targets. 
In Chapter 5, 3D-hydrogels microparticles by microfluidics are developed as biosensing element for 
miRNA detection. Firstly, the design of the double strand probe is arranged, then probe density and the 
composition of the hydrogel are established using bulk as scaffolds. Finally, this knowledge has been 
scaled down in microfluidics obtaining 3D-hydrogel biosensors for miRNA-143-3p detection, a miRNA 
involved in the early stage of Sclerosis lateral amyotrophic disease. 
Finally, in Chapter 6 are synthetically presented conclusions and future perspectives. 
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CHAPTER 2 
 
 
“Toehold-mediated strand displacement Microgels: bioassay for 
Cytomegalovirus infection diagnosis” 
 
 
 
The work described in this chapter is part of a manuscript published: 
Tania Mariastella Caputo, Annunziata Cummaro, Vincenzo Lettera, Alessia Mazzarotta, Edmondo Battista, 
Paola Antonio Netti e Filippo Causa. “One-step scalable fluorescent microgel bioassay for endogenous viral 
miR-US4-5p ultrasensitive detection”  Analyst, 2018, http://dx.doi.org/10.1039/C8AN02166J  
40 
 
1. INTRODUCTION 
Human Cytomegalovirus (hcmv) is a member of Herpesviridae family, Betaherpesviridae subfamily, 
genus Cytomegalovirus and represents a significant cause of morbidity and mortality in compromised 
population. The virus has a worldwide distribution (affecting around 60% of adults in industrialized 
countries and 100% in poorer countries)1, higher host specificity, low replication cycle and long latency 
period. Cytomegalovirus infection is often asymptomatic in immunocompetent people. However, the 
infection can induce serious clinical complications or death in new-borns and immunosuppressed 
people2,3. 
Actually, the conventional method to univocally detect the human cytomegalovirus infection is based 
on the isolation of virus from cells, by viral culture. The assay requires long time of analysis (about 4 
weeks) and is affected by low sensitivity. These conditions have led to the development of several new 
diagnostic techniques4–6. However, despite all the efforts made, a specific diagnostic test able to work in 
low-sample-volume of human fluids, avoiding preliminary steps of purification and amplification is still 
lacking. 
MicroRNAs have attracted great attention in clinical application. They are involved in a wide range of 
biological processes7–15and are used as potential biomarkers for the diagnosis and prognosis of a variety 
of diseases, including viral infections16–22. Recent works prove that viruses are not only able to modify 
human microRNA expression, but some of them23, including Beta-Herpes viruses, are also competent to 
encode for their own sets of endogenous viral microRNAs24–26. Viral microRNAs are differentially 
expressed during the viral lifecycle and they affect both viral and cellular transcript. In particular, 
endogenous hcmv microRNAs have an active role in the complex regulation of host cell metabolism and 
in establishing latency and immune evasion27,28.  
For these reasons, use an endogenous viral microRNA as a biomarker is a promising method to 
overcome some limitations associated to conventional oligonucleotide biomarkers and improve hcmv 
diagnosis. In clinical routine, indeed, in order to use human microRNAs as biomarkers, it is necessary to 
establish a physiological threshold level to distinguish healthy from infected people. Additionally, 
microRNAs are often affected by inter- and intra-individual variability29,30, which makes the threshold 
level complex to quantify31. Contrariwise, since endogenous viral microRNAs are absent in healthy 
people, their presence is indicative of infection and does not require to set a threshold level, avoiding 
misdiagnoses. Along this line, a circulating endogenous viral microRNA (hcmv-miR-UL22A-5p) has 
been used as a specific biomarker of cytomegalovirus infection after solid organ transplantation32. 
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Furthermore, it is proved that the hcmv-miR-US4-5p has a primary role in cytomegalovirus infection. 
The miR is released by the virus during the active stage of infection33 and has an effective role on the 
immune response34. Due to its recognized role, it has been validated as circulating biomarker for the 
follow-up of pharmacological therapy 35. Therefore, the circulating hcmv-miR-US4-5p might be used as 
biomarker since its presence is a clear indication of cytomegalovirus active infection. Hence, its detection 
represents an innovative approach for the accurate diagnosis of infection. 
Through the years, beads-based assays have been renowned in the analytical field for their efficiency 
in biomarker detection, including nucleic acids36. However, beads suffer of some limitations, such as the 
non-specific interactions and low kinetics of reaction. Hydrogel microparticles (e.g. microgels), 
differently, due to their solution-like environment, chemical tunability and non-fouling nature in human 
fluids proved promising in the detection of various biomolecules37–39 overcoming limitations observed 
in conventional bead based assays. In particular, microgels are easily synthesized by several strategies40, 
encoded with optical or morphological barcodes41–43 and functionalized with probes for capture and 
detection of clinically relevant biomarkers such as proteins, DNA, mRNA, and microRNA (miRNA)44–
46.  
Based on these considerations, in this chapter we have described an innovative diagnostic microgel 
assay for active cytomegalovirus infection disease, based on endogenous hcmv-miR-US4-5p detection. 
The combination of antifouling and biocompatible properties of PEG microgels with the integration of 
probe sequences allow to obtain a direct, amplification-free bioassay for specific hcmv-miR-US4-5p 
quantification. In particular, we have achieved a tuneable optical detection, based on the number of 
microgels used for assay, reaching attomolar sensitivity. 
2. EXPERIMENTAL SECTION 
2.1. Materials 
Poly(ethylene glycol) dimethacrylate average Mn 550 (PEGDMA), Acrylic acid (AAc), Potassium 
persulfate (KPS), Fluoresceine O-methacrylate, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) 
and Polyvinyl alcohol 40-88 (PVA), Dimethyl Sulfoxide (DMSO), Sodium Hydroxide, and 4-
Morpholineethanesulfonic acid sodium salt (MES) were all purchased from Sigma-Aldrich and used as 
received. The dye Methacryloxyethylthiocarbonylrhodamine B was obtained from Polyscience Inc. Tris 
buffer 1M, pH 8 was supplied by Applichem GmbH. DNA and RNA oligonucleotides were purchased 
from Metabion International AG GmbH with HPLC purification. Human serum was supplied by Lonza. 
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2.2. Probe design 
The oligonucleotide probes were designed as DNA double strand (ds) sequences appropriately tailored 
on the target sequence hcmv-miR-US4-5p, according to specific requirements. In particular, 
thermodynamic parameters, sequence alignment and folding were considered to improve the ds-probe 
stability, avoid alignment with non-specific sequences and minimize secondary structure. The target 
sequence was synthesized according to mirbase.org47 and thermodynamic parameters (melting 
temperature, stability, and folded fraction at assay condition) were predicted using appropriate tools 
(OligoAnalyzer 3.1 (IDT-Integrated, D. N. A. 2014) and Oligocalc48). Then, the ds probe length was 
carefully evaluated to allow a stable hybridization between the oligonucleotide strands at physiological 
ionic strength and predict the free energy of displacement (Gdisplacement). The alignment scores were 
predicted by mirbase.org and NCBI blast49, while folding was simulated through UNAFold web server50. 
The target recognition is based on toehold mediated strand displacement mechanism. For this purpose, 
an oligonucleotide quencher strand (Q) fully complementary to the target, is designed with an internal 
Black Hole Quencher (dT-BHQ2). This strand is partially complementary to a shorter tail (F), labelled 
with a fluorophore (ATTO647N) at the 5’terminus and a C6-spacer with amine linker on the 3’ terminus. 
Quenching efficiency and kinetics of displacements for the selected ds-probe were measured by 
spectrofluorometer. Displacement efficiency was measured mixing 5nM of pre-hybridized ds tail-
quencher with 1:1 and 1:10 target solution, in 500 µL of 100 mM TRIS buffer pH 8 enriched with 200 
mM NaCl (hybridization buffer). Moreover, ds-probe specificity was tested spiking 50 nM of non-
matching microRNA (table 1) (10-fold excess) in hybridization buffer alone and in presence of equimolar 
target viral microRNA. The emission intensity was monitored over 24 hours. Assay performance in 
complex matrixes was carried out adding 50 nM of synthetic target hcmv-miR-US4-5p in human serum 
sample (200 µL of human serum and 300 µL of hybridization buffer) in presence of 5 nM of free ds-
probe and kinetics of recovery was monitored for 24 hours by spectrofluorometer. Quenched samples 
were used as reference in order to evaluate the displacement efficiency. 
Table 1 Oligonucleotide sequences used and their thermodynamic parameters (predictions calculated setting: 5nM of DNA, 200mM of 
Na+, pH 7-8, 5°C). 
 
 SEQUENCE (5’-3’) 
Tm 
(°C) 
ΔG (kcal/mol) 
Tail strand(F) GGGGGATGTCTG 41.2 QFhyb=-23.75 
Quencher strand (Q) CAGACATCCCCCTGCACGTCCA 67.2 QThyb=-45.29 
hcmv-miR-US4-5p (T) UGGACGUGCAGGGGGAUGUCUG   
ΔGdisplacement= -21.54 
Non-matching miRNA UGAGAUGAAGCACUGUAGCUC   
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2.3. Microgel synthesis and functionalization 
Core-shell microgels were obtained through a multistep synthesis. Firstly, core nanoparticles, 
composed of 1% (w/v) PEGDMA and 0.1mM rhodamine B acrylate monomer, were synthetized by free-
radical precipitation polymerization. The reaction was carried out in aqueous solution of 1% (w/v) PVA 
using 2.2 mM of KPS as thermal initiator. The solution was heated to 65°C stirring vigorously for 7 hours 
while purged with N2 gas. Once dialyzed, the rhodamine-labelled core was used as a seed for the 
subsequent two shells polymerization. The first shell was obtained adding to the aqueous solution of core 
microgel PEGDMA 0.5% (w/v), PVA 0.5% (w/v) and KPS (1.1 mM). The solution was heated to 65 ºC 
for 6 hours in N2 atmosphere. The second shell was obtained adding to the aqueous suspension of 
core/1°shell microgels PEGDMA 0.5% (w/v), Acrylic acid 0.25% (w/v), Fluoresceine O-methacrylate 
(0.1 mM), KPS (1.1 mM) and carried out the reaction at 65 ºC for 6 hours in N2 atmosphere. The core-
shell microgels size and electrophoretic mobility were characterized by Dynamic light scattering 
(Malvern Zetasizer Nano ZS instrument, 633 nm laser, 173° scattering angle). Carboxyl groups content 
was quantified by titration before further conjugation of the probe. 
Bioconjugation optimization was performed by changing the amount of coupling agent (EDC) and the 
amino-fluorescent tail strand. First, several EDC concentrations (20, 200, 500, 1000, 2000 mM) were 
tested by reacting 1 mg of microgels and 1 nmol of fluorescent tail strand in a final volume 500 µL of 
coupling buffer (0.1 M MES pH 4.8), overnight at room temperature. Afterwards, 1 mg of microgels was 
coupled with 300, 600,1000 and 1500 pmol of fluorescent tail strand by using the optimized EDC 
concentration. The functionalized microgels were washed three times and resuspended in 500 µL of 
hybridization buffer. The amount of the tail bound to the microgel surface was calculated from the 
difference between the initial and the supernatant labelled tail concentration. The quenching step was 
performed adding 10-fold excess of quencher strand (3, 6, 10, 15 nmol) to the functionalized microgels 
and incubating overnight at room temperature. The quenched microgels were washed three times and 
resuspended in 500 µL of hybridization buffer. 
2.4. Fluorescence measurement 
Quenching efficiency and recovery of fluorescence after the toehold mediated strand displacement 
assay were recorded by spectrofluorometer and by confocal microscopy. Double strand functionalized 
microgel solutions were prepared after mixing 25 µg, 12.5 µg and 2.5 µg of microparticles to 500 
µL of hybridization buffer containing target sequences from 10-9 to 10-18M. The assay was run 
with final microgel concentration of 50 µg/mL, 25 µg/mL and 0.5 µg/mL (respectively 
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corresponding to 1.45·109, 7.25·108 and 1.45·107 microgels) and incubated at room temperature 
overnight. For the spectrofluorometer measurements the samples were analysed unprocessed, 
while were diluted to 0.5 µg/mL for the confocal microscopy analysis. Assay performance in 
complex matrixes was carried out spiking 50 nM of synthetic target hcmv-miR-US4-5p in human 
serum sample (200 µL of human serum and 300 µL of hybridization buffer) in presence of 50 
µg/mL of microgels. The kinetics of recovery was measured for 24 hours by spectrofluorometer. 
Moreover, functionalized and quenched microgels were stored at 4°C in hybridization buffer and 
stability was monitored over one year. Recurrently, 50 µg/mL of microgels were resuspended 
from the stock and fluorescence measured by spectrofluorometer. Fluorescence spectra were 
collected in a 1 cm path length cuvette with a Horiba JobinYvon model FluoroMax-4 
spectrofluorometer equipped with a Peltier temperature controller. The probe sequences were 
excited at 647nm (slit width of 5 nm) and emission spectra were collected from 667 to 750 nm 
(slit width of 5 nm). In addition, in order to quantify the rhodamine copolymerized into the core, 
microgels were excited at 548 nm and emission was collected from 568 to 650 nm (slit width of 
5 nm). Fluorescence kinetics curves were obtained by plotting the wavelength emission 
maximum as a function of the time and fitted by one phase association equation to calculate the 
specific rate constants. 
Confocal microscopy fluorescence measurements were performed by means of a Confocal laser 
scanning microscope Leica SP5 with an objective HCX PL APO CS 63x1.40 oil (Zeiss). Helium 
neon laser 543nm and 633nm were used for ATTO647N and rhodamine excitation. Power lasers 
and detector gains were kept always constant with a section thickness 3.04 airy unit, scan speed 
8000 Hz and an image size of 144.7x144.7 μm2 (resolution 1024x1024). For each target 
concentration, the sample was loaded onto µ-slide VI 0.4 ibidi (Ibidi, Martinsried, DE), and the 
images were collected. More than 200 microgels were analysed using a custom image-processing 
software (ParticleINTcalc_Dannhauser 2016V2.5). 
In addition, fluorescent measurements were acquired and analysed by a BD FACSCanto II flow-
cytometer and DIVA software (Becton Dickinson, Fullerton, CA). Measurements were carried 
out adding 106 microgels in 1mL of buffer and analysing the forward and side scattering setting 
the population in the middle of the plot. Gated the position, the particles with positive value were 
selected and for those selected was analysed the intensity of Fluoresceine, Rhodamine(PE) and 
Atto647N (APC). 
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2.5. Statistical analysis  
All experiments were performed at least three times, reported as mean ± standard deviation and 
analysed statistically by paired Student’s test. Significant difference was determined at P values 
smaller than 0.05. 
3. RESULTS AND DISCUSSION 
3.1. Probe design 
In order to develop an assay for microRNA detection we select a specific biomarker and, based 
on that, a DNA double strand probe is designed (Figure 1A). Such probe is then mounted on the 
surface of a microgel and it is capable to recognize single strand target by increasing its 
fluorescence emission (Figure 1B). Microgel assay is, indeed, based on a fluorescence increase 
upon the target addition and it is characterized by a scalable sensitivity with a limit of detection 
correlated to the number of microgels used in the assay (Figure 1C-D). The DNA double strand 
probe consists of a quencher strand (25nt) fully complementary to the target, internally modified 
with a Black Hole Quencher2 (BHQ2), and a shorter (12nt) fluorescent tail strand. When the 
Figure 1 Overview of the assay: A) Double strand probe is designed based on specific biomarker selection. B) Microgel 
functionalization and fluorescence recovery mechanism involved in target detection. C) Microgels assay working range (nM-aM) and 
D) LOD tunability is based on the number of microgels used for assay. 
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quencher and the fluorescent tail strands hybridize, the fluorophore and quencher come in close 
proximity and fluorescence quenching occurs. In presence of the target, the toehold displacement 
is initiated by its binding to the quencher strand51. The target replaces the fluorescent strand by a 
mechanism defined as “branch migration”. The branch point of quencher-target pair moves 
random walking over the domain of quencher-fluorescent tail strand. If the branch point advances 
sufficiently far the quencher strand is fully displaced and the strand exchange is complete52,53.  
To achieve high sensitivity and specificity in hcmv-miR-US4-5p identification, the DNA double 
strand probe sequences have been opportunely designed according to alignment studies and 
thermodynamic parameters simulation.  
The oligonucleotide alignment is defined by the raw score (S) and E-value. S corresponds to the 
local alignment of similar segments to our specific sequences, while E-value is the expected 
amount of random sequences that have equivalent alignment. Higher raw score and smaller e -
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Figure 2 A) Representation of alignment results for hcmv-miRUS4-5p calculated by mirbase.org  B)Fluorescence emission intensity of the 
tail labelled strand(F, 5nM) and duplex tail-quencher strand (QF, 5nM 1:1 ratio).  C) Fluorescence recovery as a function of time in toehold-
mediated strand displacement assay after addition 5nM (empty circle) and 50 nM (full circle) of hcmv-miR-US4-5p target, in homogeneous 
condition; D) Fluorescence recovery in presence of 10-fold excess of non-matching miRNA alone (black column) and mixed with the target 
(red column).
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value (10-4 order) are indicative of a significant match. From the alignment studies resulted that 
no human microRNA or circulating DNA sequences are associated to the hcmv-miR-US4-5p 
sequence. As shown, only two microRNAs align with the hcmv-miR-US4-5p sequence and they 
are ascribable to viral microRNA synthetized during the cytomegalovirus infection in other 
species (Figure 2A). In particular, miR-5620-3p has a total S of 66, E-value of 2.9 and is 
expressed by mus musculus (house mouse), while the miR1148.1 has S of 65, E-value of 3.5 and 
is expressed by Chlamydomonas reinhardtii (green alga). Alignment data suggest very high 
specificity for the selected target and consequently for the assay. 
Oligonucleotide probes must be designed considering thermodynamic and folding parameters. 
Thermodynamic parameters are accurately predicted during the design of the oligonucleotide 
double strand probes. In particular, the length of the strands is optimized to guarantee both higher 
probe hybridization in absence of target (Tm>37°C) and appropriate free energy (G) of 
displacement in presence of the target (Table 1). The G of displacement is calculated as the 
difference between the free energy of hybridization predicted for the target/quencher pair and 
that expected for quencher/tail pair (Table 1). As the G of displacement is the driven force of 
this process, the probes are designed in order to gain about -20 kcal/mol from the displacement. 
In our specific case, the predicted ΔG of displacement is -21.54 kcal/mole (Table 1). 
Figure 3 A-B) Quencher strand (Q) and C) Tail strand (T) folding simulations and their relative free energy
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Complex oligonucleotide folding or stable secondary structures could decrease the probes 
hybridization or hindered the displacement. Based on the folding simulations, stable secondary 
structures are not expected for the ds-probes presented in this work (Figure 3).  
Once optimized the design, ds-probe are synthetized and tested in solution. For our specific 
labelled tail-quencher duplex, the quenching efficiency is about 90% in hybridization buffer 
(homogeneous conditions) (Figure 2B). In the Figure 2C the fluorescence emission of ds-probe 
in presence of different amounts of hcmv-miR-US4-5p target is shown as a function of time. 
When the viral RNA target sequence is added to the hybridization buffer containing 5nM of ds-
probe in homogenous, a quick recovery of fluorescence is recorded. No relevant difference is 
observed adding 5nM and 50 nM of target (corresponding to equimolar concentration and 10-
fold excess) and in both cases, complete target displacement and subsequent recovery of the 
signal is achieved in about 5 hours, as indicated by the "plateau" region of the kinetics profile 
(Figure 2C). The time constants, calculated by the non-linear fitting of the kinetics experiment, 
resulted 1.57 hours and 1.7 hours respectively for 5nM and 50nM of miRNA target.  
Moreover, we have tested the ds-probe specificity using a not matching sequence. As showed 
in Figure 2D, no recovery of fluorescence is recorded after 24 hours when 10-fold excess of the 
target is mixed with the ds-probes. 
3.2. Microgel synthesis and functionalization 
Multifunctional microgels with core-shell architecture are obtained combining free radical 
polymerization and seeded polymerization reaction43,44. Microgels result monodispersed with a core, 
first and second shell size average of 416.2 ± 0.9, 889.4 ± 18.05 and 1002.0 ± 16.3 nm respectively (Table 
2). The outmost layer presents a net charge of -15 mV due to the copolymerization of acrylic acid that 
confers the colloidal stability and provides the carboxyl groups for the conjugation of DNA probes 
(Figure 4A).  
Several bioconjugations have been tested. From our studies result that the best assay performances are 
achieved using 500 mM of EDC (Figure 4B inset) and 1000 pmol of fluorescent tails (corresponding to 
probe density of 1.02 × 104 DNA tail probes/microgels). In such condition, after the addition of the 
quencher strands, we have reached a quenching efficiency of 76.46%. Both decreasing and increasing 
the amount of immobilized fluorescent tail, we have observed a decrease of the quenching efficiency. In 
particular, a quenching efficiency of 42.6%, 56.4% and 58.4% is measured at 300, 600, 1500 pmol 
respectively (Figure 4C).  
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Table 2 Hydrodynamic diameter (Dh) and ζ potential measurement of microgels 
 Z average (DH, nm) PDI Zeta potential (mV) 
Core 416.2±0.9 0.006 -3.67±0.287 
First shell 889.4±18.05 0.078 -6.52±0.0557 
Second shell  1002.0±16.3 0.28 -15.1±0.379 
 
 
These data are explained considering that probes are conjugates on the outmost layer of a microgel. 
Differently from the 2D surface, the oligonucleotide strands are immobilized within a three-dimensional 
polymer network of approximate radius of 200 nm and not only on a surface. Furthermore, the microgel 
shells are interpenetrated54, this means that along the thickness of the functionalizable layer, the 
innermost section could hinder the hybridization due to the reduction of the polymer network mesh size 
and the increase electrostatic repulsions. As consequence, the hybridization between the immobilized 
fluorescent tail and the quencher strand is hindered in the innermost zone of the gel and fluorescence 
background is generated. At low coupling concentrations (300 pmol), the fluorescent background due to 
innermost un-quenched probes has a greater effect on the background as confirmed by the Signal/Noise 
ratio (S/N=1.74). Increasing the functionalization to 600 and then 1000 pmol, S/N ratio increases from 
2.29 to 4.25. This because increasing the total amount of tails hybridized, the deepest un-quenched tails 
have less influence on the background and thus the efficiency of quenching is improved. Increasing the 
probe density to 1500 pmol, the efficiency of quenching decreases due to the crowding effect. 
In order to compare the homogenous and heterogeneous kinetics of displacement, we have used 50 
µg/mL of functionalized beads, corresponding to 5 nM of fluorescent probes attached on the microgel 
surface. As expected, kinetics of displacement on the microgels are correlated to the concentration of the 
added target (Figure 4D). The time constant, calculated by the non-linear fitting, is 3.36 hours when 10-
fold excess of target are mixed with microgels and 7.6 hours at equimolar amount. Therefore, in 
heterogeneous condition, a slightly lower recovery of fluorescence intensity at equilibrium is observed, 
even though more evident is the depletion of the characteristic time of the kinetic processes. Both 
phenomena can be ascribable to the limited molecular mobility of the oligonucleotide double strand 
probes at polymer interface along with a reduced accessibility of the target within the outer microgel 
layer. 
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A rigorous control over the microgels used in each reaction run is maintained through simultaneously 
fluorescence measurements of the reporter (ATTO647N) and internal reference (Rhodamine). This is 
essential to avoid false results due to a different number of analysed microparticles.  
 
3.3. Assay set-up 
Microgel beads are tested toward several assay conditions and fluorescence is measured by confocal 
laser scanning microscope (CLSM) and spectrofluorometer. CLSM is an image-based approach where 
the fluorescence emission of single particle is measured and related to the amount of target added.  
The pictures collected during the assay clearly show the microgel core/shell architecture. The core, made 
of the PEGDMA-Rhodamine copolymer (coloured in red), is surrounded by fluorescent tail strands 
emitting in the not-overlapping channel of ATTO647N (coloured in blue) (Figure 5A). For each sample, 
Figure 4 A) Schematic representation of the toehold mediated strand displacement assay on microgel beads; B) Fluorescence intensity 
measured for 50µg/mL of microgels with different functionalization grade before the quenching step. In the inset, coupling efficiency 
obtained for a fixed fluorescent tail and microgels amount increasing the EDC concentrations. Data are presented as fluorescence ratio 
between the reporter (Atto647N) and the reference dye(Rhodamine); C) Quenching efficiency of the above-mentioned functionalised 
microgels; D) Fluorescence recovery as a function of time in toehold mediated strand displacement assay after addition 5nM (empty circle) 
and 50 nM (full circle) of hcmv-miR-US4-5p target. 
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more than 100 fluorescent microparticles per image are taken and data are processed by an “in house” 
developed image analyser (Figure 5B), routinely setting many parameters. In particular, we initially set 
the threshold intensity, then we select the ROI around microgel and we measure the intensity and the 
signal-to-noise ratio. 
In order to validate the working range, the sensitivity and the limit of detection, a wide range of viral 
microRNA target concentrations is explored and the number of microgels are tuned for each assay (50 
µg/mL, 25 µg/mL and 0.5 µg/mL). We have proved that the fluorescence recovery on a single microgel 
allows the detection of the target in a dynamic working range of 10−9–10−18 M. We have not explored 
higher target concentrations since circulating microRNAs are mainly expressed in nM-fM range55. The 
minimum target presence distinguishable from the background noise has a concentration comprised 
between femtomolar to attomolar. Furthermore, as reported in Figure 5C, D and E, the recovery of 
fluorescence increases exponentially with the hcmv-mir-US4-5p concentration, while the limit of 
detection (LOD) value decreases substantially reducing the number of microgels for assay (Table 3). 
LODs in the order of 39.1 fM, 11.7 fM, 156 aM are achieved when 50 µg/mL, 25 µg/mL and 0.5 µg/mL 
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of microgels are used respectively. Thus, this microgel based assay shows a scalable sensitivity, being 
tuneable over a wide range of target concentrations. Such enhanced results are difficult to achieve with 
standard amplification free methods. 
In fact, acting as target concentrator, microgels improve the sensitivity of toehold-mediated strand 
displacement assay, increasing both the range of target detectable and the sensitivity, avoiding target 
amplification44,45,56.  
Furthermore, as shown in Figure 6A microgel assay is particularly suited for common laboratory 
equipment (e.g. spectrofluorometer and flow cytometer). We set assay conditions by using 50 µg/mL 
and 25 µg/mL of microgels. Indeed, increasing the microgel concentration, scattering events dramatically 
risen, while below 25 µg/mL it is not possible to isolate the fluorescence signal from background noise. 
For both microgel concentration tested the working range of the assay is comprised between nM to fM 
(Figure 6A). LOD of 354 fM is achieved testing 50 µg/mL of microgels. Decreasing the microgel 
concentration to 25 µg/mL, the LOD increases reaching 283 fM. Thus, we have proved that 
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Figure 6 A) Microgels fluorescence recovery measured by spectrofluorometer: using 50 and 25 µg/mL of microgels. B) Comparison 
between homogenous (5nM of free double strand probe, empty square) and heterogeneous (50µg/mL of functionalised microgels, full black 
square) assay in human serum in presence of excess of target (50nM); C) Microgel stability measured over a range of 1 years. Black square 
corresponding to quenched microgels, while red dots to un-quenched microgels. Data are presented as fluorescence intensity ratio between 
the reporter (Atto647N) and the reference dye(Rhodamine). 
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spectrofluorometer readout significantly reduces the analysis time and processing steps keeping the 
sensitivity required for the microRNA detection.  
Table 3 Non-linear regression data analysis for ds displacement assay and microgel-based assay performed in presence of hcmv-miR-
US4-5p target.by confocal laser scanner microscopy. 
 
 
Table 4 Non-linear regression data analysis for ds displacement assay and microgel-based assay performed in presence of hcmv-miR-US4-5p target by 
Fluorimeter 
Microgel 
concentration 
(µg/mL) 
slope 
Standard 
error 
(slope) 
Intercept 
Standard Error 
(intercept) 
LOD (fM) R-Sq 
50 8.339 2.201 12.009 2.37 354 0.924 
25 26.407 3.03 20.079 3.19 283 0.95 
 
 
Finally, microgels performance are tested in complex fluids, spiking the microRNA target into the 
human serum solution. As shown in Figure 6B, ds-probes conjugated on microgels (heterogeneous 
condition) are more efficient in target recognition compared to free probes in solution (homogenous 
condition). This is mainly due to the hydrophilic polymeric background of PEG that provides antifouling 
and solution-like properties to the microgel. Therefore, serum proteins are rejected from the microgel 
surface, while probes are protected within the hydrogel environment.   
Moreover, as shown in Figure 6C, microgels stability is monitored for 12 months without any 
substantial loss of fluorescence intensity, suggesting a long shelf life and assay stability. 
Microgels are also examined by a flow cytometer. Analysis have shown that is possible to discriminate 
the fluorescence emission of the particle architecture, measuring the core (Rhodamine), the second shell 
(Fluorescein) fluorescence emission (Figure 7A) and the probe contribution (ATTO647N) before and 
after the quenching (respectively unquenched and quenched condition Figure 7 B-C). As shown, the 
fluorescence ratio between the copolymerized dyes into the microgels (FITC/Rho reported as PE) is 
Microgel 
concentration 
(µg/mL) 
slope 
Standard 
error 
(slope) 
Intercept 
Standard Error 
(intercept) 
LOD (fM) R-Sq 
50 88.796 16.721 -206.65 76.053 37.12 0.93 
25 29.788 7.4 96 18.049 20.564 11.7 0.88 
0.5 27.505 1.726 86.419 1.774 0.156 0.99 
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stable for all samples measured. In addition, the signal to noise for the conjugation analysed is 
comparable with that observed by confocal microscopy (S/N= 2.53). 
 
A 
B 
C 
Figure 7 FACS measurements: A) Microgel without functionalization; B) Unquenched microgel; C) Quenched microgel 
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4. CONCLUSION 
Current diagnostic techniques for hcmv detection are time spending and expensive. We have proposed 
a ultrasensitive, specific and versatile microgel assay able to detect viral endogenous circulating 
microRNAs in body fluids, overtaking the clinical requirements of panels and threshold level settings.  
In this chapter we have designed a heterogeneous assay by using PEG microgels armed with short 
fluorescent DNA double strand probes for the specific detection of viral microRNA biomarker by 
toehold-mediated strand displacement assay.  
The combination of the antifouling and solution-like microgels properties with the fluorescent signal 
confinement of specific probe into small volume allows to perform direct target detection in complex 
fluids.  
Further, simply tweaking the assay microgel set-up, hcmv-miR-US4-5p has been detected with scalable 
sensitivity (down to about 150 aM) and over a wide dynamic range (from nM to aM). The proposed 
microgels can be also integrated in microfluidic device for in flow real time detection57. 
Therefore, the microgel assay might represent a smart platform able to diagnose cytomegalovirus active 
infections. These technologies can comply with several biomarkers, leading the way towards simpler and 
portable analytical devices.  
From the clinical point of view further investigations are still ongoing and studies on real samples and 
PCR-based diagnostic tests are planned to measure the accuracy of our technology. 
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CHAPTER 3 
 
 
“Molecular Beacons bioconjugated Microgels: bioassay for 
miRNA biomarker detection in Cancer” 
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1. INTRODUCTION 
The World Health Organization has estimated that Cancer is the second leading cause of death globally, 
with 9.6 million of deaths only in 20181. Moreover, mortality can be reduced if cancer is detected and 
treated early. Therefore, it is imperative to identify novel, more sensitive, and easy-to-perform assay for 
specific early biomarkers detection, which can be used in diagnosis and prognosis of cancers.  
MicroRNA (or miRNA) are non-coding RNA sequence of about 22-25nt. They are involved in the 
regulation of the gene expression at post-transcriptional level inducing translational inhibition or 
transcript degradation2. Because of this pivotal role, circulating microRNAs (miRNAs) have emerged as 
a new type of biomarkers for the early diagnosis, prognosis and follow up of several pathological 
conditions3, included cancer4. The miR-21 has been the most studied miRNA (along with let-7) due to 
its ubiquitous role in various biological processes5. It is involved in several positive and negative 
feedback loops and is probably one of the most dynamic miRNAs responsive to various stimuli6. It is 
proved that miR-21 expression levels are usually up-regulated in cancer7 and it functions as an 
oncogene8,9. Therefore, since dysregulation of miR-21 represents a common feature of a cancer process, 
it is often considered as an early biomarker. 
Traditional methods for detect miRNA are mainly based on amplification methods and in situ 
hybridization10,11. However, despite all the techniques developed, miRNA detection is still challenging 
because of the small size, the sequence similarity, the low abundance and intra- and inter-variability12. 
For this reason, although miRNAs have widely proved to be suitable biomarkers, their application in 
clinical practice is still limited, and the developing of innovative methods of detection is required. 
In this context, the use of molecular beacon for microRNA detection is particularly interesting. 
Essentially, a molecular beacon13 is a single strand oligonucleotide sequence containing a fluorophore 
and a quencher in its opposite ends. It comprises a central portion (loop) complementary to the target and 
two self-complementary terminal arms (stem)14,15. Because of its design, in absence of target it is 
conformed in stem-loop hairpin structure and the fluorophore and quencher are in close proximity with 
a consequent quenching of the fluorescence16. When the target hybridizes with the loop a stable duplex 
is formed and the stem is mechanically forced to open. Hence, the fluorophore and quencher are spatially 
separated and fluorescence is restored. Many studies have been focused on the practical rules to design 
molecular beacons17,18 and on their enhanced properties19. In particular, due to their unique structural and 
thermodynamic properties, molecular beacons are capable to differentiate between two target sequences 
that differ by as little as a single nucleotide20,21.  
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From their discovery, many advances in bioanalytical methods development have been carried out also 
because of the advantages offered by the molecular beacons. As proof of this, they have been integrated 
with several technologies22–30 for bioanalytes detection31–36. Moreover, molecular beacons have been 
integrated on solid surfaces and used as biosensors37–43. However, when molecular beacons are 
immobilized on solid surfaces the fluorescence background usually increases due to non-specific 
oligonucleotide-surface interaction and crowding effects44 among the immobilized oligonucleotide 
probes. As results, both the hybridization ratio and the assay sensitivity are affected. To increase signal-
to-background ratio substrate as graphene45 or gold46 or long spacer as poly(thymidine/adenosine) 
(poly(T/A)) and poly(ethylene glycol) (PEG)42 have been used. Alternatively, surface polymer coating 47 
and nucleic acid analogues48 have been used to increase the molecular beacon stability. Such 
modifications decrease the surface effect and slightly improve the mb performance. Gold surfaces 
represent a valid substrate to immobilize quencher-free molecular beacons by standard gold-thiol 
chemistry. These functionalized substrates achieve nanomolar sensitivity and high specificity49. 
Nevertheless, non-specific adhesion and non-uniform distribution of mb on the gold surface can reduce 
the biosensing performance. Molecular beacons have been also immobilized on substrates as 
graphene45,50,51, that works as a super-quencher with a long-range nanoscale energy transfer property. As 
results, when molecular beacons are immobilized on graphene oxide substrates, the fluorescence 
background strongly decreases and the signal-to-noise (hence the sensitivity) increases. These biosensors 
show single nucleotide polymorphism selectivity and low sensitivity (comprises in nanomolar to 
picomolar order), indeed, they usually require the combination with amplification methods52. However, 
for each substrate non-specific adsorption occurring in biological fluids largely impairs direct and easy 
detection of target oligonucleotides, while kinetics is depressed after immobilization on solid surface53. 
Even though the performance of surface-immobilized MBs has been significantly improved by using the 
newly developed immobilization techniques and surface treatment approaches, sensitivity was still low. 
Recent studies have proved that when molecular beacons are bio-conjugated into materials with 
solution-like property, as poly(ethylene glycol) hydrogels, fluorescence background strongly decreases54. 
In this specific case, indeed, molecular beacon hybridization is comparable to that obtained in solution.  
Based on these considerations, in this chapter is described the development of a molecular beacons-
bioconjugated microgel assay for miR-21 detection for cancer application. Core-shell microgels endowed 
with carboxylic moieties are synthetized and the molecular beacon design is optimized for the purpose. 
Then, the density of the conjugated in the outermost shell is tuned and the assay set-up. The results have 
demonstrated that such molecular beacon-conjugated microgels are capable of fM sensitivity without 
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preliminary amplification steps, single nucleotide polymorphism discrimination and reduced time of 
analysis.  
2. EXPERIMENTAL SECTION 
2.1. Materials  
Poly(ethylene glycol) dimethacrylate average Mn 550 (PEGDMA), Acrylic acid (AAc), Potassium 
persulfate (KPS), Fluoresceine O-methacrylate, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) 
and Polyvinyl alcohol 40-88 (PVA), Dimethyl Sulfoxide (DMSO), Sodium Hydroxide, 4-
Morpholineethanesulfonic acid sodium salt (MES) and water biological grade were all purchased from 
Sigma-Aldrich and used as received. The dye Methacryloxyethylthiocarbonyl-rhodamine B was obtained 
from Polyscience Inc. Phosphate buffered saline tablets were supplied by MP biomedicals. DNA and 
RNA oligonucleotides were purchased from Metabion International with HPLC purification.  
2.2. Molecular beacon design  
Two molecular beacons complementary to the miR-21 were designed. The molecular beacons contained 
a fixed loop complementary to the target made of 22 bases and a stem of 5 or 6 bases (MBS5 or MBS6). 
The 5’ terminus was modified with an ATTO647N fluorophore and a 12-carbon amino spacer while a 
BlackBerry Quencher 650 (BBQ-650) was added on the 3’ terminus. Both molecular beacons were 
suspended in nuclease-free water to a concentration of 100µM and stored at -20°C. To assess the 
specificity of molecular beacons, non-matching sequence (miR-143) and three mutants of the wild-type 
miR-21 were also tested in the hybridization assays. Specifically, for the miR-21 mutants, 1, 2, or 3 
nucleotides of the sequence were modified: miR-21-1a had one nucleotide mutated at the end of the loop 
near the stem; miR-21-1b had one mutated nucleotide in the centre of the loop; miR-21-2 had both 
mutated nucleotides in the centre and at the end of the loop; miR-21-3 had three mutated nucleotides.  
The kinetics of hybridization in presence of the wild-type miR21, the mutated miR-21 sequences and a 
non-matching miR were measured mixing 500nM of the sequences to 50nM of molecular beacon in 
500µL of PBS buffer. The fluorescence recovery as function of the time was recorded by 
spectrofluorometer. 
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Table 1 Molecular beacons and target sequences tested 
 Sequence (5’-3’) Length 
(nt) 
MBS5 CGCGCTCAACATCAGTCTGATAAGCTAGCGCG 32 
MBS6 CGCGCGTCAACATCAGTCTGATAAGCTACGCGCG 34 
miR-21 UAGCUUAUCAGACUGAUGUUGA 22 
miR-21-1a UAUCUUAUCAGACUGAUGUUGA 22 
miR-21-1b UAGCUUAUCAAACUGAUGUUGA 22 
miR-21-2 UAUCUUAUCAAACUGAUGUUGA 22 
miR-21-3 UAUCUUAUCAAACUGAUGUUAA 22 
Non-matching 
(miR-143-3p) 
UGAGAUGAAGCACUGUAGCUC 21 
The nucleotides of the loop are in italics, while those of the stem in bold underline. The mutations introduced in the 
sequences are in bold. 
 
Fluorescence spectra were collected in a 1 cm path length cuvette with a Horiba JobinYvon model 
FluoroMax-4 spectrofluorometer equipped with a Peltier temperature controller. The sample was 
excited at 647nm with a slit width of 5nm, and emission spectra were collected from 667 to 
750nm with a slit width of 5nm.  
Melting curves for both molecular beacons alone and in presence of the miRNA sequences were 
recorded to calculate their melting temperatures. Melting curves were obtained monitoring the 
fluorescence intensity as function of the temperature. In particular, 500µL of PBS buffer solution 
containing 50nM of molecular beacon alone or mixed with 500nM of miRNA was initially 
denatured (3 min 95°C), then the temperature was decreased from 95°C to 20°C, with scan rate 
of 1°C/2min. Fluorescence spectra were measured as described above, exciting the sample at 
647nm and collecting the emission intensity from 667 to 750nm.   
 
2.3. Microgel synthesis  
Microgels with multi-shell architecture were synthetized through a multistep synthesis as 
previously described. Briefly, core nanoparticles made of PEGDMA 1% (w/v) and rhodamine B 
acrylate monomer (0.1mM) were synthetized via free-radical precipitation polymerization. As 
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initiator was used KPS (2.2 mM) in PVA 1% (w/v), heating to 65ºC for 7 hours in N2 atmosphere. 
Nanoparticles were dialyzed and worked as a seed for the subsequent two shells polymerization. 
The first shell was obtained adding to the aqueous suspension of core microgels PEGDMA 0.5% 
(w/v), PVA 0.5% (w/v) and KPS (1,1 mM), heating to 65 ºC for 6 hours in N2 atmosphere. The 
second shell was obtained adding to the aqueous suspension of core/1°shell microgels PEGDMA 
0.5% (w/v), Acrylic acid 0.25% (w/v), Fluoresceine O-methacrylate (0.1 mM) and KPS (1,1 
mM). The microgels size and electrophoretic mobility were characterized by Dynamic light 
scattering (Malvern Zetasizer Nano ZS instrument, 633 nm laser, 173° scattering angle). 
Carboxyl groups content was quantified by titration before further conjugation of the molecular 
beacon. 
2.4. Molecular beacons conjugation.  
Bioconjugation was optimized coupling 1, 0.5 and 0.1 nmol of molecular beacons. Before the 
reaction 1mg of microgel was incubated in 450µL MES pH 6, while molecular beacons were 
incubated in 50µL MES pH 6 enriched with 200mM of NaCl, both for at least 5 hours. After, the 
carboxylic groups on microgel were activated using 500mM of the coupling agent EDC stirring 
vigorously for 30 min at 5°C. Subsequently, the pre-hybridized molecular beacon solution was 
added to the microgels incubating overnight at room temperature. Molecular beacons-
bioconjugated microgels (mb-microgels) were washed 3 times to remove the unreacted molecular 
beacons and resuspended in PBS buffer. For each microgel functionalization, the kinetics of 
hybridization with the miR-21 target was measured through a spectrofluorometer. For this 
purpose, 20nM of wild-type miR-21 solution was mixed with 25 µg/mL of mb-microgels in 
500µL of hybridization buffer.  
2.5. Specificity  
The assay specificity was tested adding 5 µg/mL of mb-microgels (with 0.1 nmol 
functionalization) to 20 µL of buffer solution containing 50 pM of each mutated miR-21 
sequences, 50 pM of non-matching miR (miR-143) and 50 pM of 1:1 miR21-1a/miR-143(table 
1). Moreover, mb-microgels were mixed with 50 pM of wild-type miR-21 containing 50 pM or 
5 nM of mir21-1a and 50 pM or 5 nM of 1:1 of miR21-1a/miR-143. The solution was incubated 
overnight at room temperature, images were collected and analysed.  
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2.6. Microgel assay 
The assay was easily performed mixing the microgels to the sample solution containing the 
target sequences, without preliminary steps of amplification. The solution was incubated at room 
temperature and then fluorescence recovery was measured. In particular, mb-microgels limit of 
detection (LOD) and limit of quantification (LOQ), scalable sensitivity, kinetics of hybridization, 
and specificity were measured by confocal laser scanning microscopy (CLSM).  
To estimate the LOD and LOQ 5 µg/mL of each mb-microgels were mixed with 20 µL of samples 
at different target concentrations, ranging from nM to aM, loaded into µ-slide 18 well-flat (Ibidi, 
Martinsried, DE) and incubated at room temperature overnight. In the same way, the 
concentration of mb-microgels with 0.1 nmol functionalization was decreased to 0.5 µg/mL and 
tested towards 20 µL of samples at different target concentrations.  
Kinetics of hybridizations were measured mixing 100 nM and 100 pM of wild-type miR-21 with 
5 µg/mL of mb-microgels in a final volume of 20 µL. Fluorescence intensity was collected after 
1, 3, 5 and 24 hours. The samples were analysed by CLSM-SP5 with an objective HCX PL APO 
CS 63x1.40 oil (Zeiss), by using Helium neon laser 543 nm and 633 nm. Power lasers and detector 
gains were kept always constant with a section thickness 3.04 airy unit, scan speed 8000 Hz and 
an image size of 144.7x144.7 μm2 (resolution 512x512). For each target concentration, 3 or more 
images were collected and more than 500 microgels were analysed. The images were thresholded 
by Otsu algorithm and then processed with the Image J Analyze Particles function to 
computationally determine the number of single fluorescent particles sizing in the range of 1µm.  
Furthermore, mb-microgels fluorescence intensity was measured by the means of a flow cytometer (BD 
FACS Canto II flow-cytometer and DIVA software (Becton Dickinson, Fullerton, CA)). Measurements 
were carried out adding 106 microgels in 1mL of buffer and analysing the forward and side scattering 
setting the population in the middle of the plot. Gated the position, the particles with positive value were 
selected and for those selected was analysed the intensity of Fluoresceine, Rhodamine(PE) and Atto647N 
(APC). 
2.7. Human serum analysis 
To prove the enhanced detection ability of microgels in complex fluid, the assay was also 
performed in human serum mixing 5µg/mL of mb-microgels and 20uL of human serum in which 
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was spiked 100nM of miR-21. The sample were loaded into the µwell and incubated at room 
temperature. Then, images were collected by CLSM as previously described and analysed. 
2.8. Statistical analysis  
All experiments were performed at least three times, reported as mean ± standard deviation and 
analysed statistically by paired Student’s test. Significant difference was determined at P values 
smaller than 0.05.  
To estimate the Limit of detection and the Limit of quantification the values, subtracted of the 
background and reported as mean ± standard deviation, are fitted applying a linear regression The 
LOD values is calculated as three standard error (SE) above the slope, while the LOQ corresponds 
to ten standard deviation (SD) above the slope. 
3. RESULTS AND DISCUSSION 
3.1. Molecular beacon design.  
The design of molecular beacon affects both the sensitivity and the specificity of the 
hybridization with the target. The main parameters considered during the molecular beacon 
design are the length, the sequence of the loop and the stem, as they participate in the three 
different conformational states: bound-to-target, stem-loop and random-coil. Many reviews 
focused on this field, however, nobody has already developed an assay based on PEG microgels 
functionalized with molecular beacons for miRNA detection. For this reason, to further obtain a 
performant assay, two molecular beacons, MBS5 and MBS6(table1), are properly designed and 
tested. The molecular beacons share a common loop (22nt) complementary to the miR-21 and a 
stem of 5 (MBS5) or 6 (MBS6) bases. For their design, several specific software are used to 
predict the structure and thermodynamic properties. Based on the folding predictions, secondary 
structures (Figure 1) are absent in the loop, in both sequences. Moreover, due to the high GC 
content, the stem guarantees high stability (ΔG<0) in assay conditions. 
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Figure 1 Folding simulation prediction of MBS5 and MBS6 and predicted thermodynamic parameters 
Molecular beacons are previously tested in solution. As expected, molecular beacon with a 
shorter stem (MBS5) results faster in target hybridization compared to the molecular beacon with 
a longer stem (MBS6). In particular, as shown in Figure 2A, MB5 needs 30 minutes to reach the 
complete target hybridization, while MBS6 requires about 150 minutes in the same experimental 
condition (Figure 2B). Moreover, the temperature of melting increases with the length of the stem 
varying from 72.5 °C for MBS5 to 82.5 °C for MBS6 (Figure 3). 
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Figure 2 Hybridization kinetics of molecular beacon MBS5 (A) and MBS6(B) in the presence of wild-type target miR-21 in hybridization 
buffer at rt. 
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Both molecular beacons prove an enhanced specificity in target recognition in solution. In 
particular, the hybridization kinetics and melting curve of MBS5 and MBS6 with miR-21 
containing one two or three modifications are analysed. 
 As shown in Figure 4A and B, the fluorescence increment, due to the hybridization with the 
mutated miR, is negligible compared to the wild-type miR-21. 
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Figure 4 Hybridization kinetics of molecular beacon MBS5 (A) and MBS6 (B) in the presence of wild-type and mutants miR-21. 
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Figure 3 Melting and annealing profiles of MBS5(A) and MBS6 (B). Molecular beacons were melted from 20 to 95°C (red circle) and 
annealed (black square) in hybridization buffer. Moreover, MBS5 and MBS6 were priory melted to 95°C and then annealed until 20°C in 
presence of 500nM (10fold excess respect to MB) of miR-21 wild type (blue triangle). 
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The melting curves confirm that with proper design, molecular beacons have the potential to 
distinguish single-base variations in target miRNA. Indeed, the melting temperature of the miR-
MB duplex decreases as the number of point mutations increase (Figure 5-Table 2).
 
 
Table 2 Melting temperature (Tm) predicted and calculated of MBS5 and MBS6. The temperatures 
refer to 50mM of molecular beacons in PBS buffer without the addition of miR or mixed with 
500nM miR. 
 Tm (°C) Predicted Tm (°C) Calculated 
MBS5 MBS6 MBS5 MBS6 
Without Target 66.2 73.2 72.5 82.5 
MBS+miR21 57 57.5 53.5 
MBS+miR21-1a 48.9 44.5 38.5 
MBS+miR21-1b 50.13 37.5 32.5 
MBS+miR21-2 40.05 28.5 - 
MBS+miR21-3 26.6 24 - 
MBS+miR-143 - - - 
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Figure 5 Melting and annealing profiles of MBS5 (A) and MBS6 (B). Molecular beacons were melted from 20 to 95°C and then annealed 
until 20°C in presence of 500nM (10fold excess respect to MB) of miR-21 wild type, mutated miR-21 (-1-a, -1-b, -2, -3) and non-matching 
miR-143. 
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3.2. Microgel synthesis and bioconjugation.  
Microgels, synthetized combining free-radical and seeded polymerization reaction, have a final 
diameter of 1 µm and 1.71 µmoli/mg of carboxylic moieties for further functionalization, as 
described in Chapter 2. They have presented colloidal properties and enhanced stability in the 
time. In order to set the optimal density of molecular beacon, several bioconjugations have been 
carried out. Before the carbodiimide coupling, molecular beacons are pre-hybridized in MES 
buffer with higher ionic strength to help maintain the MB stem-loop structure. Such step is 
introduced to prevent that not annealed molecular beacons diffuse into the innermost layer of the 
microgel shell, where they can be hindered to conform in their darker hairpin structure, thus, 
increasing the background fluorescence.  
From the bioconjugation analysis has been observed that both the signal-to-noise and the assay 
sensitivity are affected increasing the number of molecular beacons coupled to the microgel  
(Figure 6). In particular, the signal-to-noise ratio increases about twice reducing the 
functionalization from 1 nmol to 0.1 nmol for both molecular beacons (1.78- and 1.6-fold for 
MBS5 and MBS6 respectively).  
These results are consistent with other studies and are especially associated with the crowding 
effect between molecular beacons. At higher density of functionalization, the hybridization with 
the target is reduced due to conformational limitations imposed by the proximity of stem-loop 
molecular beacons or by miR-MB duplexes. Therefore, decreasing the molecular beacon density 
such constraints are reduced and the signal-to-noise increases.  
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3.3. Assay sensitivity and kinetics 
The mb-microgels are analysed to define their sensitivity and kinetic of hybridizations. The 
results obtained (Figure 7) testing a wide range of target miR-21 (from nM to aM) clearly show 
that the limit of detection (LOD) and limit of quantification (LOQ) increase decreasing both the 
length of the molecular beacon stem and the functionalization ratio. In particular, microgels 
functionalized with MBS5 reach 71.2 pM, 3.41 pM and 105.77 fM of LOD and 215 pM, 10.32 
pM and 320.5 fM of LOQ, coupling respectively 1, 0.5 and 0.1 nmol of molecular beacons. 
Microgels functionalized with MBS6, instead, achieve 443.85 pM, 238.5 pM and 324.8 fM of 
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LOD and 1.34 nM, 465.8 pM and 984 fM of LOQ, conjugating respectively 1, 0.5 and 0.1 nmol 
of molecular beacons (Table 3).
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Table 3 Data analysis for mb-microgels assay  
Mb-microgel 
(5µg/mL) 
SE SD R- sq Slope 
LOD 
 (pM) 
LOQ 
 (pM) 
MBS5-m 1nmol 3.942419 6.828468 0.9989 0.3164 71.21 215.817 
MBS5-m 0.5nmol 0.761043 1.318165 0.999 1.2763 3.4082 10.3280 
MBS5-m 0.1nmol 3.237186 5.503217 0.993 0.1717 0.1057 0.32051 
MBS6-m1nmol 23.57572 40.83433 0.958 0.3036 443.85 1345.00 
MBS6-m0.5nmol 34.325 59.45262 0.7918 0.8224 238.56 465.820 
MBS6-m 0.1nmol 6.155026 10.46354 0.989 0.163 0.3248 0.98434 
 
Furthermore, mb-microgels assay shows a scalable sensitivity (Figure 8), indeed, decreasing the 
concentration of microgels to 0.5µg/mL per assay the LOD further decreases. Specifically, 
MBS5-microgels reach a LOD of 12.1 fM and LOQ of 36.7 fM, while MBS6-microgels reach 
13.7 fM of LOD and 41.6 fM of LOQ (Table 4). 
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Figure 8 Target detection performances of mb-microgels with concentration scaled to 0.5ug/mL. 
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Table 4 Data analysis for mb-microgels assay  
Mb-microgel 
(0.5µg/mL) 
SE SD R-sq Slope 
LOD  
(fM) 
LOQ  
(fM) 
MBS5-m 0.1nmol 3.454826 5.873204 0.9976 0.0016 12.11 36.7 
MBS6-m 0.1nmol 3.915771 6.65681 0.9969 0.0016 13.72 41.6 
 
 
 
Established that the lowest functionalization is the most performing in terms of sensitivity, we 
have explored the kinetic of hybridizations characteristic of each coupling by spectrofluorometer 
and confocal microscope. The kinetics of hybridizations obtained by spectrofluorometer confirm 
that decreasing the functionalization the hybridization time decreases too. In particular, MBS5 
and MBS6-microgels are able to recognize the target in less than 1 hour when the 0.1 nmol 
functionalized microgels are measured (Figure 9A-B). Increasing the functionalization degree, 
the kinetics of hybridizations slow down, however, all microgel types (0.5 nmol and 1 nmol) 
tested reach the plateau region in about 5 hours.
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Figure 9 MBS5-(A) and MBS6-(B) microgels kinetic of hybridizations measured by spectrofluorometer 
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The kinetics of hybridizations have been calculated also by confocal microscopy, decreasing the 
microgel concentration to 5 µg/mL for assay. The measurements carry out on microgels show 
that MBS5-microgels with higher functionalization need more than 5 hours to completely 
hybridize with the target miR-21 (Figure 10A). Decreasing the functionalization to 0.5 nmol the 
process is completed in 5 hours. However, the most interesting performances are obtained by the 
microgels with lower functionalization degree. Indeed, these mb-microgels reach a complete 
hybridization in 1-3 hours even at low target concentration (Figure 10A). Microgels conjugated 
to MBS6, compared to those functionalized with MBS5, show slower kinetics of hybridization 
as observed also in solution. However, the microgels with lower functionalization (0.5 nmol and 
0.1 nmol) reach the completely target hybridization in a maximum of 5 hours (Figure 10 B).  
The performance of molecular beacon probes free in solution has usually been considered to be 
much higher than that of molecular beacons coupled to a variety of solid substrates such as 
microarray or microparticles. For this reason, molecular beacon functionalized surfaces have not 
found many applications in biomedical field compared to the free molecular beacon in solution. 
Thus, the enhanced performance demonstrated in this study are mostly ascribable to PEG 
microgel properties. Indeed, they are capable to swell and retain large volume of water generating 
a solution-like environment. This environment is approximate to a solution for the molecular 
beacon. Furthermore, molecular beacons are endowed with a long 12 carbon spacer to reduce the 
steric interactions between the surface of the polymer and itself, that can decrease the signal-to-
noise ratio. 
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Figure 10 MBS5(A) and MBS6(B) kinetic of hybridizations measured by confocal microscope.
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3.4. Assay specificity  
The capacity to discriminate between oligonucleotide sequences with a single or multiple 
mutation is a fundamental requirement involved in the developing an analytical assay. Microgels 
specificity has been tested in presence of non-matching sequence (miR-143-3p) and miR-21 
mutants. As shown in the Figure 11, MBS5-microgels are very stable towards non-matching 
sequence. A considerable fluorescence increment is measured only after the hybridization with 
the wild-type target. MBS5-microgels show a slight increase of fluorescence only in presence of 
mir-21-1a and mir-21-1b. Such increase corresponded to the 13.1% and 14.3% of the maximum 
fluorescence measured after the hybridization with the wild-type miR-21 at equivalent 
concentration (Figure 11). 
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Figure 11 MBS5-microgels specificity tested towards wild-type miR-21, four mutated miR-21 sequences and a non-matching sequence 
(miR-143). 
MBS6-microgels, instead, show higher specificity and any fluorescence increment is measured 
also when they are mixed with mir-21-1a and mir-21-1b (Figure 12). Both mb-microgels are 
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stable in presence of mixture of miRNAs, as miR-21-1a and miR-143. Moreover, when these 
sequences are added to the wild-type target, they do not interfere or contribute with its 
recognition. As results, the same increase in fluorescence intensity is measured both when miR-
21-1a is alone and when it is combined with miR-143 added 1:1(50 pM) or 1:100(5 nM) to the 
wild-type miR-21.  
These results confirm that mb-microgels due to the superior properties of molecular beacon in 
target recognition can be usefully applied in case of single nucleotide polymorphism (SNP) or in 
presence of homologous sequences.  
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Figure 12 MBS6-microgels specificity tested towards wild-type miR-21, four mutated miR-21 sequences and a non-matching sequence 
(miR-143). 
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3.5. Human serum assay 
MBS5-microgels and MBS6-microgels are added to a small volume of human serum and tested 
without prior manipulation of the sample. As expected both MB-microgels are capable to detect 
the wild-type target in human serum with results analogous to those obtained in hybridization 
buffer (Figure 13). Indeed, due to the anti-fouling nature of PEG, interfering proteins circulating 
in body fluids (in this case in human serum) are rejected from the surface of microgels. Thus, 
microgels permit to minimize non-specific interaction allowing the diffusion of oligonucleotides 
or small molecules within the polymer network. This result highlights the enhanced efficiency of 
functionalized microgels as mix-read biosensors, which represents an innovative and interesting 
field in biosensing.  
 
 
 
Microgels are also analysed by flow cytometer. As clearly showed in the Appendix, the emission 
intensity of Fluorescein and Rhodamine is stable for all the sample analysed, while a broad curve 
in Atto647N (APC) is observed due to the presence of molecular beacon in stem-loop or 
hybridized conformation. From the data analysis results that microgels achieved sensitivity 
Figure 13 Mb-microgels assay in human serum. Fluorescence ATTO 647N intensity value is normalized to the rhodamine 
intensity.
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comparable to static measurement, with signal distinguishable from the background down to 100 
fM target concentration (Table 5).  
Moreover, the signal-to-background ratio of the mb-microgels analysed by CLSM in PBS/serum 
and by FACS are similar, confirming the high stability and versatility of these microgels (Figure 
14). 
Table 5 FACS analysis results 
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Figure 14 Signal-to-ratio of MBS5-microgels calculated by CLSM in PBS and in serum and by FACS  
 
  
 Fitc Rho 
Atto 
647N 
Atto/Rho 
MBS5-microgel 0,1nmol 602 719 363 0,504 
Target 100nM 583 693 674 0,972 
Target 1nM 585 697 408 0,585 
Target 500pM 595 707 402 0,568 
Target 1pM 588 700 366 0,522 
Target 100fM 564 674 345 0,511 
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4. CONCLUSION 
Many efforts have been made in detection methods, however, diagnostic tests for miRNA still 
suffer of important limitations such as the cost, the time of analysis, the complexity in specific 
probes design and the technical difficulties in results interpretation. 
We have synthetized PEG-microgels functionalized with molecular beacons for the detection of 
miR-21. Such miRNA is highly expressed in cancer cells and is free to circulate in human fluids 
in many pathological states associated with cancer. Indeed, the miR-21 is usually used as 
biomarker in for the early diagnosis, in the prognosis and the follow-up of several types of 
cancers.  
We have tuned the probe density of the molecular beacons and the concentration of microgels 
achieving fM sensitivity. We have proved that mb-microgels are characterized by enhanced 
specificity as they can distinguish the wild-type target from a mutant, even for a single nucleotide. 
Furthermore, microgels are stable in the presence of higher amount of interfering 
oligonucleotides and in complex fluids, as human serum.  
Combining an optimized probe design with the solution-like and antifouling properties of the 
microgels, the fluorescent signal is efficiently concentrated into a small volume allowing to 
specifically detect the miR-21 in low fM order, without amplification steps in 3 hours, using only 
20 µL of sample. In this study the hydrogel technology has been specifically developed for miR-
21 detection, however, it can be tuned for several miRNAs but also for mRNA and other single 
strand oligonucleotides leading the way towards non-invasive, sensitive and portable analytical 
devices. 
In conclusion, the aim of this work was to develop a sensitive and specific technology to detect 
circulating biomarkers. The system has proved to be suitable for the purpose, the diagnostic 
application on real sample are still preliminary and require additional tests to be clinically 
validated. 
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APPENDIX 
FACS measurements 
Dot plot of MBS5-microgels in hybridization buffer 
 
Dot plot of MBS5-microgels mixed with target miR-21 100nM in hybridization buffer 
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Dot plot of MBS5-microgels mixed with target miR-21 1nM in hybridization buffer 
 
 
 
 
Dot plot of MBS5-microgels mixed with target miR-21 500pM in hybridization buffer 
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Dot plot of MBS5-microgels mixed with target miR-21 1pM in hybridization buffer 
 
 
 
 
Dot plot of MBS5-microgels mixed with target miR-21 100fM in hybridization buffer 
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CHAPTER 4 
 
 
“Microgels for long oligonucleotide sequence detection” 
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1. INTRODUCTION 
Sensitive and specific detection of oligonucleotides is extremely important in clinical application. It is 
proved that higher levels of nucleic acids are free to circulate in body fluids during many clinical 
disorders. As consequence, free oligonucleotides in human fluids may serve as minimally invasive 
biomarkers1,2.  
The ‘liquid biopsy’3 technology aims to detect these circulating oligonucleotides in human fluids to 
diagnostic several diseases avoiding invasive procedures as biopsies. Circulating RNA molecules4 such 
as protein-coding messenger RNAs (mRNA), are correlated to cancer5,6 or prenatal disorders7. Cell-free 
long coding RNAs (lncRNA) have been proposed as biomarkers for diagnosis and prognosis of many 
pathologies as non-small cell lung cancer8, acute myocardial infarction9, bladder cancer10 hepatocellular 
carcinoma11. DNA molecules are also free to circulate in human fluids and they are involved in many 
processes as immunity12, aging13 or are used as biomarker in prenatal screening14, stroke15, infarction16, 
trauma17, infection18. However, one of the most studied clinical application is the detection of circulating 
tumour DNA (ctDNA) as non-invasive assessment of cancer19–21. 
To support such applications many analytical methods have been developed and validated. In particular, 
since the polymerase chain reaction (PCR) was introduced in 1985, PCR has become the most applied 
technology especially in medical communities22. PCR, qRT-PCR23 and digital PCR24,25 techniques are 
routinely used since they offer enhanced sensitivity and specificity. However, these techniques require 
complex, expensive, time-consuming and hard-working procedures that have induced scientists to 
developed alternative analytical methods. Therefore, many new technologies for oligonucleotide 
sequencing and quantification have been made26. PCR-free biosensing methods have been developed and 
many of the most innovative technologies relay on optical27 or electrochemical28 sensors combined with 
DNA hybridization. These biosensors are often combined with enzyme-based signal amplification to 
achieve better sensitivity29 or modified with oligonucleotide analogues30 to increase the specificity.  
In this chapter the performances of microgels in long oligonucleotide sequence detection were 
investigated. As proof-of-concept experiment reported herein, two long single strand oligonucleotide 
with high sequence similarity were chosen as initial targets. For each target, double strand probe- and 
molecular beacon-microgels are designed and tested. Firstly, the practical rules to design probes for long 
oligonucleotide target detection were set. Then microgels performance in long target detection were 
evaluated and compared to those observed with short oligonucleotides in chapter 2 and 3.  
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The aim is to lead the way forward further application of functionalized microgels for the detection of 
long oligonucleotide biomarkers as mRNA, lncRNA, cDNA and with the appropriate modifications to 
double strand DNA. This because there is an increasing demand for sensitive and specific assays able to 
detect the mentioned oligonucleotides in complex fluids, especially for liquid biopsy application. 
2. EXPERIMENTAL SECTION 
2.1. Materials  
Poly(ethylene glycol) dimethacrylate average Mn 550 (PEGDMA), Acrylic acid (AAc), Potassium 
persulfate (KPS), Fluoresceine O-methacrylate, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) 
and Polyvinyl alcohol 40-88 (PVA), Dimethyl Sulfoxide (DMSO), Sodium Hydroxide, 4-
Morpholineethanesulfonic acid sodium salt (MES) were purchased from Sigma Aldrich. The dye 
Methacryloxyethylthiocarbonyl-rhodamine B was obtained from Polyscience Inc. Phosphate buffered 
saline tablets were supplied by MP biomedicals. DNA and RNA oligonucleotides were purchased from 
Metabion International with HPLC purification. 
2.2. Probe design 
To detect long oligonucleotide sequences, probe design approaches described in chapter 2 and 3 were 
compared. For this purpose, double strand and molecular beacon probes were designed and tested. 
DNA double strand (ds) probes were designed based on the target sequences P1 and P2 (Table 1). The 
target sequences have length of 111 nucleotides and 70% of sequence similarity. The sequence 
alignment, folding considering and thermodynamic parameters were considered to improve the 
specificity and enhance the sensitivity of the target detection. The alignment scores were estimated by 
NCBI blast, while folding was predicted through UNAFold web server. Thermodynamic parameters 
(melting temperature, G H S) were predicted using appropriate tools (OligoAnalyzer 3.1 (IDT-
Integrated, D. N. A. 2014) and Oligocalc). The target recognition was based on a displacement assay 
mediated by a toehold strand mechanism as already discussed in chapter 1-2. The oligonucleotide 
quencher strand (Q) fully complementary to the target, was designed with an internal Black Hole 
Quencher (dT-BHQ2). This strand is partially complementary to a shorter tail (F), labelled with a 
fluorophore (ATTO647N) at the 5’terminus and a C6-spacer with amine linker on the 3’ terminus (Table 
1). Quenching efficiency and kinetics of displacements for the selected ds probe were measured by a 
spectrofluorometer. Displacement efficiency was calculated mixing 5nM of pre-hybridized ds probe with 
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50, 5 and 0.5 nM of target solution, in 500 µL of 100 mM TRIS buffer pH 8 enriched with 200mM NaCl 
(hybridization buffer). Moreover, ds-probe cross-reactivity was tested spiking 500 nM of homologous 
Target P2 (Table 1) (10-fold excess) in 500 µL of hybridization buffer containing 50 nM of ds-P1and 
monitoring the emission intensity over 24 hours. Subsequently, 500 nM of the specific target P1 was 
added and recovery of fluorescence monitored for 24 hours. In the same way, cross-reactivity was 
measured for 50 nM of ds-P2, spiking 500 nM of homologous P1 and following the fluorescence 
emission for 24 hours, then target P2 was added and recovery of fluorescence recorder for further 24 
hours. 
Two molecular beacons (MBP1-MBP2) were designed based on the folding of the specific target P1 
and P2. The molecular beacons contained a stem of 6 bases and a loop complementary to the target site 
made of 24 (P1) or 23 (P2) bases. The 5’terminus was modified with an ATTO647N fluorophore and a 
12-carbon amino spacer while a BlackBerry Quencher 650 (BBQ-650) was added on the 3’ terminus. 
Both molecular beacons were suspended in nuclease-free water (100 µM final concentration) and stored 
at -20°C. The sequence alignment, the folding considering and thermodynamic parameters were 
predicted using the software aforementioned. To assess the specificity of both molecular beacons cross-
reactivity experiments were carried out as already described for the ds-probes. The kinetics of 
hybridizations in presence of the specific target was measured mixing 500 nM of the sequences with 50 
nM of molecular beacon in 500 µL of hybridization buffer. Melting curves for both molecular beacons 
were made to identify their melting temperatures. Melting curves were obtained monitoring the 
fluorescence intensity as function of the temperature. In particular, 500 µL of hybridization buffer 
solution containing 50 nM of molecular beacon alone or mixed with 500 nM of target was initial 
denatured (3 min 95°C), then the temperature was decreased from 95°C to 20°C, with a scan rate of 
1°C/2min. Moreover, kinetics of hybridizations and melting curves were performed in presence of a 
shorter target, containing only the sequence complementary to the loop, in the same experimental 
condition. The binding of P1 and P2 target (111) was investigated by means of fluorescence titration 
experiments. Titration experiments were carried out at 25 °C in 500 µL of hybridization buffer, by 
stepwise addition (2 or 4 μL) of target P1/P2 solutions (2.5 μM) to a cell containing a fixed concentration 
(50 nM) of MBP1/MBP2 solution. After each addition of target, the solution was allowed to equilibrate 
and then fluorescence spectra were collected. Titration curves were obtained by plotting the recovery of 
fluorescence measured versus the target concentration. The dissociation constant Kd, was estimated from 
this plot by fitting the resulting curve by non-linear curve fit (dose-response function). 
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Fluorescence spectra were collected in a 1 cm path length cuvette with a Horiba JobinYvon model 
FluoroMax-4 spectrofluorometer equipped with a Peltier temperature controller. The sample was excited 
at 647 nm with a slit width of 5 nm, and emission spectra was collected from 667 to 750 nm with a slit 
width of 5 nm.  
2.3. Microgel synthesis and bioconjugation 
Microgels with multi-shell architecture were synthetized through a multistep synthesis as described in 
chapter 2 and 3 and functionalized with double strand and molecular beacon probes. In the first case, 
bioconjugation was carried out coupling 1.5, 1 and 0.5 nmol of pre-hybridized ds-probe P1 and P2. 
Molecular beacons were conjugate on microgels using 0.5, 0.25 and 0.1 nmol of probes MBP1 and 
MBP2. Before the coupling reaction, 1 mg of microgel was incubated in 450 µL MES pH 6, while ds-
probe and molecular beacon probes were incubated in 50 µL MES pH 6 enriched with 200 mM of NaCl, 
both for 5 hours. After, the carboxylic groups on microgels were activated using 500 mM of the coupling 
agent EDC stirring vigorously for 30 min at 5°C. Subsequently, the solution containing the probes was 
added to the microgels and the reaction was carried out overnight at room temperature. Functionalized 
microgels were washed 3 times to remove the unreacted probes and resuspended in hybridization buffer.  
Kinetics of hybridizations on microgels were measured through a spectrofluorometer. 50 µg/mL of ds-
P1 microgels (0.5 nmol) were mixed with 500 nM of Target P1 (111nt) in a final volume of 500 µL. 
Moreover, 50 µg/mL of MBP1- and MBP2-microgels (Low, Medium and High concentration) were 
mixed with 500 µL of hybridization solution containing 500 nM of target P1 and P2 both as long or short 
sequence. 
2.4. Microgel assay 
The assay was carried out mixing the functionalized microgels to the sample solution containing the 
target sequences, without preliminary steps of amplification. The solution was incubated o/v at room 
temperature and fluorescence emission analysed by confocal laser scanning microscopy (CLSM).  
To estimate the working range, the limit of detection (LOD) and quantification (LOQ), 5 µg/mL of each 
microgel batch was mixed with 20µL of samples at different P1/P2 target concentrations, ranging from 
nM to fM. The solution was loaded into µ-slide 18 well-flat (Ibidi, Martinsried, DE) and incubated at 
room temperature overnight. Fluorescence intensity was measured by CLSM-SP5 with an objective HCX 
PL APO CS 63x1.40 oil (Zeiss), by using Helium neon laser 543 nm and 633 nm. Power lasers and 
detector gains were kept always constant with a section thickness 3.04 airy unit, scan speed 8000 Hz and 
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an image size of 144.7x144.7 μm2 (resolution 512x512). For each target concentration, 3 or more images 
were collected and more than 500 microgels were analysed. The images were thresholded by Otsu 
algorithm and then processed with the Image J Analyze Particles function to computationally determine 
the number of single fluorescent particles sizing in the range of 1µm. 
2.5. Statistical analysis  
All experiments were performed at least three times, reported as mean ± standard deviation and 
analysed statistically by paired Student’s test. Significant difference was determined at P values smaller 
than 0.05.  
To estimate the Limit of detection (LOD) and the Limit of quantification(LOQ), the values, subtracted 
of the background and reported as mean ± standard deviation, were fitted applying a linear regression. 
LOD values were calculated as three standard error (SE) above the slope, while the LOQ corresponded 
to ten standard deviation (SD) above the slope. 
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Table 1 Sequence, length, modifications and thermodynamic parameters of the DNA probes and targets used in microgel assay. All parameters are calculated by IDT-Integrated, D. N. 
A. "Technologies. OligoAnalyzer 3.1. Web setting respectively 50nM and 200mM as oligonucleotide and Na+concentration. 
Modifications are reported in Italics, while the molecular beacon stem in bold underline. ΔGd is the free energy of displacement.  
 
 
 
 
 SEQUENCE (5’-3’) LENGTH 
(nt) 
Tm (°C) ∆G 
(Kcal/mol) 
∆H 
(kcal/mol) 
∆S 
cal/(K·mol) 
Tail P1 Atto647N-A GAG CGG TCT GAT-C6-NH2  
 
13 50.121 -14.25 -95.9 -263.27 
Quencher-P1 ATC AGA CCG CTC (dT-BHQ2)CA ATG CCA AAC TCT TCA 
 
30 72.49  -34.5 
 Gd=-17.3 
-235.1 -646.8 
Tail P2 ATTO647N-ATGGCCAAAGCC-C6-NH2 12 49.27 -13.75 -89 -242.64 
Quencher-P2 GGC TTT GGC CA(dT-BHQ2) CGG CGC AAG ACA GTT AGT 
 
30 77.49 -38.4 
Gd=-21.78 
-242.8 -659.05 
MBP1 NH2 -C12- (ATTO647N)GGCGCG-GACCGC TCTCAATGCC AAACTCTT-CGCGCC (BBQ650)  36 69.2 Stem=-6.78 -52.5 -153.34 
MBP2 NH2 -C12- (ATTO647N)GGCGCG-TCATCGTGCC GACTTCTATGCCC-CGCGCC (BBQ650)  35 70.6 Stem=-6.23 -51.3 -149.15 
P1 SHORT AAG AGT TTG GCA TTG AGA GCG GTC  24 68.51 -27.78 -188.9 -514.49 
P2 SHORT GGG CAT AGA AGT CGG CAC GAT GA  23 70.13 -27.98 -182.6 -498.53 
P1 
(NC000964.3) 
CATTATTTCA AATGCGTCAT GCACGACAAA TTGCCTTGCG CCTGTTGTAA AAGTGCTGGA 
TGAAGAGTTT GGCATTGAGA GCGGTCTGAT GACTACAGTT CATGCGTATA C 
111 85.1 -132.76 -911.6 -2511.16 
P2 
(CP017631.1) 
CATTGTTTCC GTGGCGTCAT GCACC ACTAA CTGTCTTGCG CCGATGGCCA AAGCCTTGCA 
TGACAGTTTC GGGATAGAAG TCGGCACGAT GACGACCATT CATGCCTATA C 
111 89.23 -143.19 -921.6 -2509.78 
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3. RESULTS AND DISCUSSION 
In this chapter the microgels biosensing capability of detect long oligonucleotide sequences is 
investigated. To do this we have compared the analytical sensitivity of hydrogels engineered with two 
different probes: double strand and molecular beacons. Furthermore, to demonstrate the efficiency of our 
hydrogel assay, two DNA sequences (P1 and P2 table 1) with a high degree of homology (about 70%) 
are selected as Target molecules. 
3.1. Double strand-microgel assay 
Double strand probes are properly designed based on P1-P2 Target sequences. The ds probe results 
from the hybridization between a short-labelled tail (F) and a longer strand internally modified with a 
quencher (Q). The mechanism of detection consists of a double strand displacement assay as already 
discussed in chapter 2. Briefly, when the tail-F and the quencher-Q strands hybridize a consequent 
quenching of fluorescence is measured. In presence of the target complementary to the Q strand, an 
energetically favourable displacement process starts (G displacement about -20 kcal/mol) and stable 
Target-Quencher duplex is formed. This event causes a recovery of fluorescence directly correlated to 
the amount of target detected. However, in this case, the recognition between the quencher and the target 
is localized on a small portion (<30nt) of the target sequence (>100). For that reason, the specific target 
site has been opportunely selected in order to have the higher sequence variability, favourable G 
displacement and less hindered folding. To achieve enhanced sensitivity, the length of the ds-probe P1 
and P2 are tuned and their folding is simulated. Adjusting the length of the probe thermodynamic 
parameters are optimized and ΔG of displacement of -17.3 and -21.7 kcal/mol are respectively predicted 
for the P1 and P2 (Table 1). Stable secondary structures that could decrease the hybridization ratio are 
not predicted from the folding simulations (Figure 1 A- B). Once synthetized, ds-probes are previously 
tested in solution and then mounted on microgels.  
After the addition of the quencher a strong fluorescence decrease has been measured in solution for 
both P1 and P2 probes, with quenching efficiency assess to 95% and 89% for QF-P1 and QF-P2 
respectively (Figure 1C-D). Regarding the kinetics of displacement in solution, when QF-P1 is tested the 
displacement process is completed in about 3 hours using 10-fold excess of target ss P1 (Figure 1E). 
However, decreasing the target concentration the kinetics of hybridization are slower and less efficient. 
A maximum displacement of 25% is recorded in 5 hours adding 500pM of target. The ds-P2 results less 
efficient in target recovery compared to ds-P1 in the same experimental condition. Indeed, after 6 hours 
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displacement efficiency of 60%, 25% and 12% is achieved using 50nM, 5nM and 500pM of Target ss 
P2 (Figure 1F).
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Figure 1 Ds-Probe study: folding simulation (P1-A, P2-B), fluorescence analysis (P1-C, P2-D) and kinetics of hybridizations (P1-E, P2-F) 
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Cross-reactivity experiments have been carried out to prove the specificity of the probes. As clearly 
shown in Figure 2, in presence of high concentration of homologous sequence, both ds-probe QF-P1 and 
QF-P2 are very stable and fluorescence increment is not recorded for 24 hours. Then, the specific target 
is spiked into the solution and a significant recovery of fluorescence is measured. Such results confirm 
that our optimized ds-probes have improved specificity toward target with high sequence similarity, an 
essential requirement in oligonucleotide detection.  
Double strand probes have been bioconjugated on the microgels, by carbodiimide chemistry. Several 
concentrations are tested, and the best results are obtained conjugating 0.5nmol of pre-hybridized ds 
strand probes. After the functionalization, microgels are analysed by CLSM. Quenching efficiency of 
76.96% and 51.8% is measured for dsP1-microgels and dsP2-microgels (Figure 2A-B).
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Figure 2 Cross-reactivity experiments: ds-P1 (A) and ds-P2 (B) probes were monitored in presence of the correspondent homologous 
Target ss P2 and P1(black square). After that, the specific target P1(blue square) and P2 (red square) is added and fluorescence emission 
collected for the following 24hours. 
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Figure 3 Fluorescence intensity measured by CLSM of quenched and unquenched probe P1 (A) and P2(B) 
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The assay is performed, as already described in chapter 2; by mixing the ds-microgels with the sample 
containing the target strand. The solution is incubated a room temperature until equilibrium is reached 
and then the fluorescence emission is measured collecting images by CLSM or recording the emission 
spectra by a spectrofluorometer. Previously manipulations of the sample are avoided, due to the 
antifouling properties, solution-like environment and signal concentrator capability of microgels, as 
already discussed in chapter 2 and 3. 
The assay sensitivity has been estimated testing several target concentrations from µM to aM. The 
results indicate that the working range of the assay is comprised between 10-6 - 10 -9M for both ds-P1 and 
ds-P2-microgels (Figure 4). Microgels functionalized with ds-P1 reach LOD of 530.83 pM and LOQ of 
1.6 nM while those coupled to ds-P2 achieve LOD 813.43 pM and LOQ 2.4 nM (Table 2). 
1uM 500nM100nM 50nM 1nM 700pM500pM300pM 1pM 500fM
0
200
400
600
800
1000
1200
1400
1600
1800
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 r
e
c
o
v
e
ry
 (
a
.u
.)
Target ss P1
 P1-microgel
1uM 500nM100nM 50nM 1nM 700pM500pM300pM 1pM 500fM
0
10
20
30
40
50
60
70
D
is
p
la
c
e
m
e
n
t 
(%
)
Target ss P1
 P1-microgel
1uM 500nM100nM 50nM 1nM 700pM500pM300pM 1pM 500fM
0
200
400
600
800
1000
1200
1400
1600
1800
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 r
e
c
o
v
e
ry
 (
a
.u
.)
Target ss P2
 P2-microgel
1uM 500nM100nM 50nM 1nM 700pM500pM300pM 1pM 500fM
0
10
20
30
40
50
60
D
is
p
la
c
e
m
e
n
t 
(%
)
Target ss P2
 P2-microgel
A B 
C D 
Figure 4 Double strand probe functionalized microgels performance. Fluorescence intensity recovery measure for P1- (A) and P2-
microgel -(C) after addition of the target and their correlated percentage of displacement(P1-B/P2-D). 
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Table 2 Data analysis of ds-microgel assay 
 
 
The kinetics of displacement for both dsP1- and dsP2- functionalized microgels have been monitored 
by spectrofluorometer. The analysis confirms that a more efficient recovery of fluorescence is obtained 
by P1-microgels compared to P2-microgels in the same experimental condition (Figure 5). In particular, 
50 µg/mL of P1-microgels achieve about 30% of recovery in 4 hours in presence of 10nM of target ss 
P1 while P2-microgels reach about 10% of fluorescence recovery spiking 10nM of Target ss P2.
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Figure 5 Kinetics of displacement of P1- and P2-microgels. 
 
 
ds-microgel 
(5µg/mL) 
SE SD R-sq Slope 
LOD  
(fM) 
LOQ  
(fM) 
P1-microgel 
0.5nmol 
28.1028 47.77 0.866 0.2970 530.83pM 1.6nM 
P2-microgel 
0.5nmol 
49.69 84.47 0.857 0.347 813.43pM 2.46nM 
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These results prove that microgel opportunely modified with double strand probes can be applied for 
the detection of long oligonucleotide sequence. The ds-microgels assay confirms enhanced specificity in 
target recognition, even in presence of high similar sequences. The assay allows the detection of 
biomarkers with length over 110nt, at last in 5 hours with working range comprises between 10-6 and 10-
12 M. However, the sensitivity and assay time can be further improved to better meet the requirements of 
an amplification-free assay.  
3.2. Molecular beacon-microgel assay 
As discussed in chapter 3, the design of the molecular beacon has a great effect on the sensitivity, the 
hybridization time and the specificity of detection. In this study, the two molecular beacons MBP1 and 
MBP2 are firstly designed based on the folding prediction of the target. The portion of the target sequence 
characterized by lower self-hybridization and with a higher sequence variability (Figure 6 A-B) is chosen 
Target ss P1 Target ss P2 
MBP1 MBP2 
A B 
C D 
Figure 6 Folding simulation of the target ss P1 (A) and P2(B). The arrows indicate the target site complementary to the 
loop of the Molecular Beacon P1(C) and Molecular Beacon P2(D) 
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as the complementary sequence of the molecular beacon loop (Figure 6 C-D). Moreover, molecular 
beacons are designed with the stem of six nucleotides to guarantee a low fluorescence background and 
higher specificity, as already proved (chapter 3). 
As for the double strand probes, molecular beacons are synthetized and studied in solution before the 
immobilization on the microgel shell. The melting profile reveals a temperature of melting significantly 
higher than that predicted by OligoAnalyzer. Melting temperatures of 75°C and 80.5°C have been 
measured for MBP1 and MBP2 (Figure 7 A-C), instead of 69.2°C and 70.6°C (Table 1). This gap can be 
explained as the OligoAnalyzer software do not take into account of the possible contribution of the 
fluorophore/quencher pair. 
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Figure 7 Melting curve and hybridization kinetics of molecular beacon used in this study. Melting profile of MBP1(A) and MBP2 (C) is 
obtained plotting the normalized fluorescence intensity as function of the temperature. In the inset is plotted the folded fraction vs the 
temperature. The melting point (Tm) is the inflection point of the curve. Kinetics of hybridization of MBP1 (B) and MBP2(D). in the inset the 
melting curve of the solution. 
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The kinetics of hybridizations prove that the hybridization between molecular beacons and long 
oligonucleotide targets occurs faster compared to ds-probe, in the same experimental condition. In the 
first 100 minutes of contact MBP1 recognizes the 87% of the target, while MBP2 captures the 56% of 
Target ss P2 (Figure 7 B-D).  
Moreover, additional investigations about the thermodynamic properties of the probe have been carried 
out. For each MB the constant of dissociation (kd) is calculated by fluorescence titration and the curves 
are fitted by dose/response equation (Figure 8). From the analysis results that MBP1 and MBP2 have 
respectively kd of 42nM and 49nM (in line with those observed in other studies31–33). 
 
As done for ds-probe, cross-reactivity experiments have been carried out to prove the MB specificity 
towards the homologous target. Curves collected confirmed that both MBP1 and MBP2 in presence of 
high concentration of homologous sequence are very stable and fluorescence recovery is not recorded 
for 24 hours. A quick fluorescence intensity increment is recorded after the spiking the specific target 
into the solution (Figure 9A-B).
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Subsequently, molecular beacons have been bioconjugated on microgels by carbodiimide chemistry. 
As widely discussed in chapter 1-3, when molecular beacons are immobilized on solid surfaces the probe 
density have a pivotal role on the sensitivity. For this reason, the analytical performances of microgels 
functionalized with 0.1nmol (L), 0.25nmol (M) or 0.5nmol (H) of MB probes have been tested. For each 
functionalization is measured the working range and the limit of detection and quantification. From the 
analysis of the data, MBP1 results more sensitive compared to MBP2, with working range comprises 
between 10- 6-10-15 M for MBP1-(L) and MBP1-(M) and 10- 6-10-12 M for MBP1-(H) (Figure 10 A-C-E). 
Regarding the assay sensitivity MBP1-(M) achieves LOD of 37.82 fM and LOQ of 114.6 fM while MBP-
(L) reaches LOD of 76.14 fM and LOQ of 230.75 fM. Increasing the concentration of immobilized 
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Figure 9 Cross-reactivity experiments: MBP1 (A) and MBP2 (B) probes were monitored in presence of the correspondent homologous 
Target ss P2 and P1(black square). After that, the specific target P1(blue dots) and P2 (red dots) is added and fluorescence emission 
collected for the following 24hours. 
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probes the sensitivity decreases, indeed, MBP1-(H) has LOD of 1.32 and LOQ of 4.01 pM (Table ). 
MBP2-microgel show generally less sensitive performance (Figure 10 B-D-F) with LOD of 274 pM, 
5.09 pM and 1.06 pM and LOQ of 835 pM, 15,44 pM and 3,206 pM respectively for MBP2-(L) and 
MBP2-(M) and MBP2-(H) (Table ). 
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Figure 10 Molecular beacon bioconjugated microgels performances in long oligonucleotide target detection. MBP1- (A) and MBP2- (B) microgel with 
0.1nmol functionalization (L); MBP1-(C) and MBP2- (D) microgel with 0.25nmol functionalization (M); MBP1- (E) and MBP2- (F) microgel with 
0.5nmol of functionalization (H).  
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The mb-microgels show faster hybridization rate compared to ds-microgels (Figure 11). In particular, 
the medium (M) functionalization combines enhanced sensitivity and improved hybridization kinetics. 
MBP1-microgels with low and medium functionalization hybridize with the target (80% of effective 
recovery) at most in 100 minutes (Figure 11 A), while MBP 2 achieves 50% of target hybridization in 
the same experimental condition (Figure 11 B).  
 
Considering all the data obtained it has been hypothesized that the less efficiency of MB2 probe could 
be ascribable to the folding of the target site. Hence, to prove our hypothesis and verify if mb-microgels 
are affected by the target structure or are independently capable to detect long oligonucleotide sequence 
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Figure 11 Kinetics of hybridization of MBP1 (A) and MBP2(B). Fluorescence recovery of low(L), medium(M) and high(H) functionalized 
microgels is recorder in the time, mixing 50ug/mL of microgels with 500nM of Target (111nt). 
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Figure 12 Hybridization kinetics and melting curve and of MBP1 and MBP2 in presence of the short Target P1 and P2 
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with the same sensitivity and specificity exhibited for miRNA targets, both MBP1 and MBP2 have been 
tested using short P1/P2 target (24 and 23n Table 1). The kinetics of hybridization of MBP1 and MBP2 
with the short target results similar to those obtained for the long target in solution. In 200 minutes 
complete recovery is achieved by MBP1 (Figure 12A) and MBP2 (Figure 12B). As expected, their 
melting curves (Figure 12A-B inset) are also comparable.  
Moreover, mb-microgels have been tested toward short target P1 and P2. As shown in Figure 13- and 
Figure 14-A, all the MBP1 and MBP2 functionalized microgels are very stable when mixed with the 
similar P2 and P1 short target. Their fluorescence background is equivalent to the mb-microgel control 
measured in absence of target. The specific target, instead, causes an increment of fluorescence 
distinguishable from the background. MBP1-microgels show working range (Figure 13 B-C-D), LOD 
and LOQ very similar to long oligonucleotide target P1, for all the functionalization tested (L-M-H) 
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Figure 13 MBP1-microgels cross-reactivity experiment results (A). Molecular beacon bio-conjugated microgels performances in short 
oligonucleotide target detection measured for MBP1- (L) 0.1nmol of immobilized probes (B); MBP1- (M) 0.25nmol -(C); and MBP1- (D) 
0.5nmol (H). 
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(Table 3). However, analysing the data collected for MBP2-microgels assay, the assay sensitivity results 
improved when the short P2 target is used (Figure 14B-C; Table 4). These results confirm that the 
sensitivity is correlated to the folding and in particular, to the self-hybridization of the target site. 
Analysing the portion of the target sequence that hybridizes with molecular beacon, we have calculated 
that only the 8.5% of this portion is self-hybridized in P1, while in P2 the 25% of the sequence is folded 
and not available for the hybridization. This explains the increased sensitivity observed in the case of the 
short P2 target. This short sequence, indeed, is not hindered or affected by stable secondary structures 
(Figure 14D) and it is completely free to hybridize with the MBP2 conjugated on the microgel surface. 
Hybridization kinetics are consistent with those observed for long oligonucleotide target P1 and P2 
(Figure 15A-B) 
500nM 100nM 1nM 500pM 100pM 1pM 500fM 250fM 1fM
0
50
100
150
200
250
300
350
400
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 r
e
c
o
v
e
ry
 (
a
.u
.)
Target short P2
 MBP2-(L)
500nM100nM 1nM 500pM100pM 1pM 500fM 250fM 100fM 1fM
0
200
400
600
800
1000
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 r
e
c
o
v
e
ry
 (
a
.u
.)
Target short P2
 MBP2-(M)
M
B
P
2-
(L
)
M
B
P
2-
(L
) +
 T
 P
1 
50
0p
M
M
B
P
2-
(L
)+
 T
 P
2 
50
0p
M
M
B
P
2-
(M
)
M
B
P
2-
(M
) +
T 
P
1 
50
0p
M
M
B
P
2-
(M
)+
 T
 P
2 
50
0p
M
M
B
P
2-
(H
)
M
B
P
2-
(H
) +
T 
P
1 
50
0p
M
M
B
P
2-
(H
)+
 T
 P
2 
50
0p
M
0
200
400
600
800
1000
1200
1400
1600
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 (
a
.u
.)
 Cross-reactivity MBP2-microgel
A B 
C D 
Figure 14 MBP2-microgels cross-reactivity experiment results (A).Molecular beacon bio-conjugated microgels performances in short oligonucleotide 
target detection measured for MBP1- (L) 0.1nmol of immobilized probes (B) and MBP1- (M) 0.25nmol -(C). D) Folding prediction of the short target 
P2. 
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Figure 15 Kinetics of hybridizations of MBP1 (A) and MBP2(B). Fluorescence recovery of mb-microgels was recorder in the time, mixing 
50ug/mL of microgels with 500nM of short Target (P1-24nt; P2 23nt). 
Table 3 Data analysis of Molecular Beacon P1-microgel assay. MBP1-microgels (with 0.1nmol (L), 0.25nmol (M) and 0.5nmol (H) 
bioconjugation density) are tested in presence of long single strand oligonucleotide Target or the correspondent short target 
Table 4 Data analysis of Molecular Beacon P2-microgel assay. MBP2 microgels (with 0.1nmol (L), 0.25nmol (M) and 0.5nmol (H) 
bioconjugation density) are tested in presence of long single strand oligonucleotide Target or the correspondent short target. 
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This study has evidenced that molecular beacon bio-conjugated microgels are also efficient for the 
detection of long oligonucleotides sequences. The design of the probe must be opportunely tailored on 
the structural properties of the target and the probe density must be optimized on the microgel surface. 
Due to the enhanced properties of molecular beacons, high specificity is achieved as proved by cross-
reactivity experiments. Moreover, the combination of these probes with the solution-like property of the 
hydrogel material and its capability of concentrating the fluorescence signal in a small volume allows to 
reach pM sensitivity in short time of analysis. Following these guidelines, specific and sensitive 
analytical assays based on microgels can be developed for a variety of target of interest. 
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4. CONCLUSION 
In this chapter the guidelines to detect long oligonucleotide sequences by microgel-based assay have 
been investigated. The assay is developed using two oligonucleotides (111nt) with 70% of sequence 
similarity as targets. Microgels are functionalized with double strand or molecular beacon probes, 
specifically designed, and their performance in term of sensitivity and specificity are investigated. 
This study has allowed to establish the instruction for the design of specific probes and we have 
demonstrated that the folding and alignment are fundamental parameters to take into consideration, 
during the design. In particular, we have proved that the target zone, comprises into the long 
oligonucleotide sequence, must not exceed the 8.5% of self-hybridization to obtain an assay with good 
sensitivity. 
In conclusion, both double strand and molecular beacon-microgel probes ensure high specificity, 
however, molecular beacon-microgels achieve better sensitivity with LOD in fM order as observed for 
short oligonucleotide sequences in the chapters 3, in reduced time of analysis. By combining what we 
have learned on the design of probes with the enhanced properties of microgels, a simple assay for the 
detection of long-circulating oligonucleotide biomarkers such as mRNA and lncRNA may be further 
developed. 
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CHAPTER 5 
 
 
“3D-Hydrogel Microparticles: mix-read bioassay for 
oligonucleotide detection. Case study of miR-143-3p detection as 
early biomarker in Amyotrophic lateral sclerosis” 
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1. INTRODUCTION 
In this chapter we have designed 3D one step functionalized hydrogel microparticles by microfluidic 
for microRNA (miRNA) detection. In biosensing application, three-dimensional (3D) functionalized 
materials represent the ideal choice since they combine the advantages of biorecognition in solution, as 
the faster kinetics of reactions and low signal background, with those observed on solid surface1–4. To 
achieve this goal, it is necessary to optimize the design and density of the capture probe, but above all, 
to fine tune the environment in which probes are immobilized.  
Immobilization on solid surfaces5–17 allow high-throughput analysis and parallel screening of several 
oligonucleotide sequences18, however, immobilized probes suffer of same limitations19,20. In particular, 
on solid surfaces, the electrostatic repulsion between probe-probe21,22, together with the steric hindrance 
between probe-target duplex23,24 and the non-specific oligonucleotides adsorption25 affect the 
hybridization efficiency. Regarding the hybridization rate, the design of the probe, its length and the GC 
content play a crucial role1,26–28. Furthermore, based on the immobilization methods biosensors suffer of 
inhomogeneous signal distribution and low conjugation reproducibility29. 
Contrariwise, 3D substrates offer higher capacity of immobilization compared to 2D surface.  
Considering similar probe concentrations for the conjugation, indeed, the crowding effects decrease in 
3D and more target/probe complex are formed, increasing the sensitivity and reducing the 
background30,31. Furthermore, tailoring the probe design and the linkage chemistry, probes are 
homogeneously distributed into the whole volume and their density is finely tuned32.  
In this context, three-dimensional materials have demonstrated to be particularly suitable for the 
development of biosensors capable of detect oligonucleotides, small molecules and drugs. Biosensor 
made by three-dimensional (3D) nitrogen-doped graphene (NG) and Fe3O4 nanoparticles have been 
developed as sensing film and functionalized with oligonucleotide probes by Chen33. Compared to solid 
surfaces, the highly porous 3D NG had a large surface area, improved the sensitive detection of DNA 
with excellent selectivity, fast responses, and a low detection limit. Nanocube heads/TiO2 nanowire 
(NW) arms (PB-TiO2) have been developed for efficient three-dimensional interfacial sensing of small 
molecules and cellular activities34. Biocompatible 3D porous silica in which was immobilized the 
Acetylcholinesterase (AChE) has been used as matrix to develop biosensors for the detection of 
organophosphorus pesticide (OPs)35. Furthermore, hydrogels microparticles have been synthetized by 
flow lithography and functionalized using methacrylate probes obtaining a 3D functionalized network 
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by Doyle’s group36. The particles are used to capture proteins and oligonucleotides19,37,38 and the 
quantification is usually associated with optical amplification of the signal, after the hybridization assay.  
Moreover, since the environment of the 3D network influences the biosensor sensitivity and specificity, 
it must be as far as possible similar to an ideal solution. Concerning this, the nature of the materials has 
a pivotal role, affecting both the diffusion of the molecules and the probe/target hybridization39. 
Polyethylene glycol (PEG) hydrogels are suitable materials due to their chemical flexibility, antifouling 
properties, biocompatibility40-41, high water content and tuneable network structure42. The tuneable 
network confers size exclusion ability as the polymer mesh size can be finely tuned to specifically allow 
the diffusion and reaction of target molecules of different size, improving the assay sensitivity43,44. 
Furthermore, it has been proved that 3D functionalized polymer network offers not only enhanced 
sensitivity but also better specificity since probes spaced further apart hybridize less with mismatch 
sequences26. 
Among the various approaches for hydrogels synthesis, microfluidic technique represents the most 
promising methods for the production and functionalization of microparticles. Droplet microfluidics, in 
particular, reduces the costs, synthesis time and reagent consumption compared to the conventional 
techniques, achieving a large production of monodisperse microparticles per hours (105 particles)38,45–47. 
As proof, we have designed a specific double strand probe for the miR-143-3p detection and we have 
integrated it into the hydrogel microparticles produced by microfluidics. MiRNAs48,49 are short non-
coding RNA sequences, widely recognized as biomarkers in several diseases50–52. Recently, Waller et al. 
showed that miRNA-143-3p expression levels are increased in the serum of amyotrophic lateral sclerosis 
(ALS) patients, consequently53, the miRNA has been validated as circulating biomarker for ASL early 
diagnosis. Amyotrophic lateral sclerosis (ALS) is one of the most common neurodegenerative diseases 
with a prevalence of 6-8 people per 100,000 per year. ALS is characterized by a selective degeneration 
of motor neutrons with a consequent progressive muscle wasting and leads to death within 2-5 from the 
symptom onset54. Unfortunately, until now, there is an average delay of 12 months from symptom onset 
to a confirmed diagnosis, typically midway through the patient’s disease course. Actually, the main 
challenge is focused on the research of non-invasive diagnostic methods for the early disease diagnosis55–
57. The diagnosis delay may exclude patients from enrolling in clinical trials, for this reason, ASL early 
diagnosis is fundamental to prolong survival and quality of life.  
Three dimensional-hydrogels microparticles can be comprised into mix-read biosensor assays as they 
are capable to detect the miRNA directly in human serum, easily mixing them with the sample and 
reading the fluorescence turn-off. The enhanced properties showed, prior tested with miRNA-143-3p, 
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results to be useful for several biomarkers recognition, paving the ways for diagnosis and prognosis of 
many different diseases.  
2. EXPERIMENTAL SECTION  
2.1. Probe design and density 
Oligonucleotide probes were designed for the selective and specific miRNA fluorescence detection 
according to a double strand (ds) displacement assay. Alignment, folding and thermodynamic studies 
were made using appropriate tools (BLAST, UNAfold, IDT-Integrated, D. N. A. "Technologies. 
OligoAnalyzer 3.1. Web." (2014)) in order to design probe with optimized properties and achieve 
enhanced target recognition capability, stability and appropriate difference in free energy of 
displacement. All the probes and synthetic target (DNA/RNA) were purchased from Metabion with 
HPLC purification and were re-suspended in water (Sigma Aldrich Molecular biology grade). The DNA 
probe was designed based on the miRNA-143-3p sequence (21 nt), and its length was properly improved 
to achieve higher stability, specificity and ∆G of displacement in presence of the target. The probes were 
tested in solution, in bulk-hydrogels and then in 3D-hydrogel microparticles. 
Solution studies were carried out using a short DNA tail (*Fprobe) modified with a fluorophore with at 
5’terminus and a longer DNA strand internally modified with a quencher (*Qprobe). Kinetic of 
hybridizations were performed mixing 50nM of the pre-hybridized *FQ-probe with 500nM and 50nM 
of target miR-143-3p in a 500uL of PBS enriched with 200mM NaCl (hybridization buffer). Melting 
curve of DNA double helix into separate random coils is monitored by fluorescence, heating 50nM of 
QF until 80°C and then annealing the solution to 10°C with scan rate 1 degree C/min. Constant of binding 
was calculated by titration of *F 50nM with Q* 2.5 µM in a final volume of 500 µL of PBS enriched 
with 200 mM NaCl (hybridization buffer). The titration curves were obtained by plotting α versus the Q 
concentration. The association constant Ka, expressed by the inverse of the molar concentration, was 
estimated from this plot by fitting the resulting curve to an independent and equivalent binding site 
model. 
All solution fluorescence measurements were collected in a 1 cm path length cuvette with a Horiba 
JobinYvon model FluoroMax-4 fluorometer equipped with a Peltier temperature controller. The samples 
were excited at 647 nm with a slit width of 5 nm, and emission spectra were collected from 667 to 750 
nm with a slit width of 5 nm  
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To simulate the diffusion and hybridization within the 3D polymer network studies were previously 
performed in bulk. Functionalized bulks were synthesized using UV free radical photopolymerization 
between PEGDA and fluorescent oligonucleotide, properly modified with methacrylamide moieties. 
Several bulks with different PEGDA and oligonucleotide concentrations were prepared and tested. The 
mixture composed of PEGDA (MW 700 Da) at different concentrations (10-15-20% w/v) in 
hybridization buffer, darocur as initiator and fluorescent methacrylate oligonucleotide (*Fb) at different 
concentrations (1μM-5μM) was strongly mixed and then purged with high purity nitrogen for 5 minutes 
to remove the excess of oxygen that may interfere with the free radical polymerization. Then, 100 μL of 
the mixture was carried out in 96-optiplate, illuminated with the UV lamp (λ = 365 nm and power-lamp 
= 21.7mW/cm2) for 5 minutes leading to complete polymerization. Then the bulks were washed several 
times with hybridization buffer and fluorescence intensity was collected. Bulks were put in contact with 
100 µL of partially complementary quencher strand (*Qb) both in equimolar or 5-fold excess 
concentration (1µM-5µM/5µM-25µM) and kinetics of quenching were recorded for 5 days. After the 
quenching step, bulks were washed several time to remove all the excess of quencher and resuspended 
in hybridization buffer. In the last step the target was added in final concentration of 10 µM and the 
kinetics of recovery recorder until 7 days. All fluorescence measurements were carried out by the means 
of a 2300 EnSpire multilabel reader (Perkin-Elmer, Waltham, MA). Fluorescence was measured from 
the top of the plate, with excitation wavelength of 647 nm, and emission wavelength at 667 nm, height 9 
mm and 500 number of flash. 
In 3D-hydrogel microparticles synthesis, probes sequences are the same used in solution with the 
exception of the fluorophore, which has been removed from the immobilized short DNA tail (T-DNA, 
12 nt) sequence and added to the free to diffuse longer DNA sequence (F-DNA, 21 nt), complementary 
to the specific target. When the F-DNA and T-DNA partially hybridize into the 3D hydrogel network, 
the microparticles become fluorescent. In presence of the target, the F-DNA and the target hybridize so 
that low fluorescence background signal is registered. Fluorescence intensity was measured by Confocal 
laser scanning microscopy (CLSM) with λex 633 nm λem 650-700 nm, using water objective 25X.  
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 Table 1 Sequence, length, modifications and thermodynamic parameters of the DNA probes and RNA targets used in solution and in 3D-
hydrogel microparticles assay. All parameters are calculated by IDT-Integrated, D. N. A. "Technologies. OligoAnalyzer 3.1. Web setting 
respectively 50nM and 350mM as oligonucleotide and Na+concentration. TF/QF*hyb represent the free energy gained from the partially 
complementary T-DNA/F-DNA or F*probe/Q*probe duplex; FTarthyb/*QTarhyb is the free energy gained from the fully complementary 
Target/F-DNA or Target/Q*probe duplex; Δdisplacement is the free energy gained after T-DNA/F-DNA de-hybridization and Target/F-
DNA hybridization 
 
Table 2 Sequence, length, modifications and thermodynamic parameters of the DNA probes and RNA targets used in bulk assay. All 
parameters are calculated by IDT-Integrated, D. N. A. "Technologies. OligoAnalyzer 3.1. Web, setting respectively 50nM and 350mM as 
oligonucleotide and Na+ concentration. 
 
2.2. Microfluidic synthesis of 3D-hydrogel microparticles and characterization 
The synthesis of microparticles was performed using a glass microfluidic device bought from Dolomite. 
The chip is made of two inputs for the continuous and disperse phase, a fine orifice where the two 
opposite channels converge, and an output. The sizes of the device are 22.5 mm × 15.0 mm × 4 mm 
(length × width × thickness) with wide channels cross-section of 100μm × 300 μm (depth × width) and 
channels cross-section at junction of 100 μm × 105 μm (depth × width). Microparticles were synthesized 
using light mineral oil (LMO, Sigma-Aldrich) mixed with non-ionic surfactant Span 80 (5 % v/v, Sigma-
Aldrich) as a continuous phase and a water solution of poly(ethylene glycol) diacrylate (PEGDA, MW 
700 Da, Sigma-Aldrich) (10-15-20 % w/v) with photoinitiator darocur (0.1% v/v with respect to the total 
Probe 
5’-
modification 
sequence (5'-3') Int 
3’-
modificati 
nt Tm ΔG (Kcal/mol) 
ΔH 
(kcal/mol) 
ΔS 
cal/(K·mol) 
F*probe ATTO647N 
GCA CTG TAG 
CTC 
 Acrydite 12 47.58 
TF/QF*hyb = 
 -13.39 -92.00 -253.45 
T-DNA  
GCA CTG TAG 
CTC 
 Acrydite 12   
  
Q*probe  
GAG CTA CAG 
TGT TTC ATC 
TCA 
BHQ2  21 62.81 
FTar/*QTarhyb = 
-22.62 -160.80 -445.23 
F-DNA  
GAG CTA CAG 
TGC TTC ATC 
TCA- 
 
ATTO647
N 
21     
Target  
UGAGAUGAAG
CACUGUAGCU
C 
  21  ΔGdisp= -9.23   
Not-
matching 
seq 
 
UAGCUUAUCA
GACUGAUGUU
GA 
  22     
Probe 
5’-
modification 
sequence (5'-3') Int 
3’-
modificati 
nt Tm ΔG (Kcal/mol) 
ΔH 
(kcal/mol) 
ΔS 
cal/(K·mol) 
*Fb ATTO647N 
TGA AAT CGG 
TTA 
 Acrydite 12 39.9 
*QFbhyb = 
 -11.01 -85.40 -239.84 
*Qb  
T AAC CGA TTT 
CTG ATG GTG 
CTA 
BHQ2  21 64.73 
*QTbhyb= 
-24.05 
-166.80 -460.27 
*Tb  
GAG CUA CAG 
UGC UUC AUC 
UCA 
    ΔGdisp= -13.04   
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volume, Ciba) as dispersed phase. Methacrylate oligonucleotide probes were mixed in the dispersed 
phase to reach final concentration of 1μM. The reaction occurs by a UV free radical photopolymerization 
between PEGDA and oligonucleotide, properly modified with methacrylamide moieties. Droplet 
emulsions were achieved adding in the first channel water solution and continuous phase in the other. 
Solutions were injected using high-precision syringe pumps (neMesys-low pressure) to ensure stable 
flow and reproducibility. This system was mounted on an inverted microscope (IX 71 Olympus). The 
droplets formation was supervised using an objective with 5x magnification and 0.12 numerical aperture 
and recorded with a CCD camera ImperxIGV-B0620M that allow to record up to 259 frame per second. 
Once emulsion was formed, it was cross-linked outside the chip using an UV lamp at 365 nm wavelength 
at 6.38W/cm2 power lamp for about 2 minutes obtaining a complete polymerization. Then, microparticles 
were collected in an eppendorf and washed several times with different solvents (diethyl ether, ethanol 
and milliQ water-tween solution (0.05 % v/v)) in order to remove all the residual oil and surfactant. After 
washing, microgels were stored at 4°C in buffer solutions until further use. Our buffer was obtained 
mixing 1x PBS (MP biomedicals), NaCl (Sigma-Aldrich) 200 mM and tween-20 (Sigma-Aldrich) at 
0.05% v/v in milliQ water.  
Hydrogels microparticles were characterized by scanning electron microscopy a FE-SEM Ultra Plus 
(Zeiss) microscope at 20 kV. For sample preparation, the microparticles solution was fixed on a 
microscope slide, air-dried and then sputtered with a 10 nm thin gold layer. Studies on the swelling of 
microparticles were carried out loading 20 μL of microparticles diluted solutions (about 100 
microparticles) into μ-slide 18 well-flat (IBIDI, Martinsried, DE). Images in both swollen and dry 
conditions were collected with confocal laser scanning microscopy (CLSM Leica SP5- with an Objective 
HC PL FLUOROTAR 20x0.5 DRY and a scan speed of 8000 Hz). Then, images were analysed by 
ImageJ software to obtain diameter and calculate volume of microparticles in both conditions in order to 
apply equilibrium swelling theory58. Diffusion studies were carried out following by confocal laser 
scanning microscopy (CLSM). In particular, 10 μL of PEGDA 15% microparticles functionalized with 
1 μM of methacrylate oligonucleotide (about 100 microparticles), were loaded onto μ-slide 18 well-flat. 
The microparticles were mixed with 10 μL of 2 µM of target miRNA-143-3p and 2 µM Albumin-
fluorescein isothiocyanate conjugate (BSA Sigma-Aldrich) solution. Samples were illuminated at CLSM 
Leica SP5 using appropriate wavelength (Helium-neon λex 633, Helium-neon λex543, Argon λex 488 
nm) and fluorescence images of microparticles were collected in the time. 
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2.3. Assay set up in buffer and Human serum  
The 3D-hydrogel assay comprises two steps: (I) Tail hybridization and (II) Target hybridization step 
(fig1). All experimental steps were performed at room temperature in both hybridization buffer (1x PBS, 
NaCl 200 mM and tween-20 at 0.05% v/v) and human serum (Lonza). Regarding the first step (I) 100 
μL of microparticles-Tail solution (~25∙103 particles and ~6 pmol of Tail), were put in contact with F-
DNA 10x (~60 pmol) in 1.5mL DNA-low Bind tube (epperdorf). The solution was stirred until use for 
three days and then washed several times with hybridization buffer. Then 1 μL of this solution was diluted 
in 30 μL of buffer, added in μ-Slide VI 0.4 (IBIDI, Martinsried, DE) and therefore the fluorescence 
intensity was measured by CLSM. In the second step (II), 2μL of 3D-functionalized hydrogel 
microparticles (~330 particles and ~60 fmol of Tail), were mixed with different Target concentrations 
(from 10-4 M to 10-12M in buffer solution) and incubated at room temperature to define the limit of 
detection (LOD) and quantification (LOQ).  
Assays performances were also tested in human serum. The target 2 µM was spiked in 200 μL of serum 
and mixed with 300μL of hybridization buffer contain the 3D-hydrogel microparticles. Then 1 μL of this 
solution was diluted in 30 μL of hybridization buffer and fluorescence images collected by CLSM. 
2.4. Specificity assay  
3D-hydrogel microparticles were tested mixing 2μL of microparticles-Tail-F solution (~330 particles 
and ~60 fmol of Tail) with 500 nM of non-matching sequence miR-21 and 500nM of miR-21/miR-143-
3p 1:1 and incubating at room temperature overnight.  
2.5. Statistical analysis  
All experiments were performed at least three times, reported as mean ± standard deviation and 
analysed statistically by paired Student’s test. Significant difference was determined at P values smaller 
than 0.05. To estimate the Limit of detection and the Limit of quantification the values, subtracted of the 
background and reported as mean ± standard deviation. are fitted applying a linear regression The LOD 
values is calculated as three standard error (SE) above the slope, while the LOQ corresponds to ten 
standard deviation (SD) above the slope. 
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3. RESULTS AND DISCUSSION 
3.1. Probe design and density optimization  
To develop a sensitive fluorescence assay based on 3D functionalized hydrogels, three important 
parameters have been considered: the design of the probe, the density of immobilized molecules and the 
diffusion through the polymer network, as extensively described in chapter 1.  
Firstly, the probe is accurately designed in order to specifically hybridize with the target and is tested 
in solution. Subsequently, three different concentrations of PEG-hydrogel bulk (10-15-20%) are 
synthetized and tested in order to optimize the probe density and tune the diffusion within the hydrogel 
network. Once these important parameters have been set, 3D functionalized hydrogel microparticles have 
been synthetized in one step by microfluidics. Firstly, probes are appropriately designed in term of 
alignment, folding and thermodynamics, then kinetics of hybridization and constant of binding (kb) are 
measured in solution. The mechanism of detection is based on double strand displacement assay. From 
the alignment studies is predicted that the probe has Evalue of 3E-3 for the hsa-miR143-3p and does not 
align with sufficient specificity with other human oligonucleotide sequences. The ING5 mRNA 
(NM_032329.5) is the nearest in term of alignment obtaining Evalue of 48. From the folding simulation 
results that the probe is free from self-secondary structures that could decrease the hybridization ratio 
(Figure 1) 
 
 
B A 
Figure 1 Folding simulation of the Tail(A) and Quenche(B)r strands using UNAFold and setting 50nM of oligonucleotide, 200mM of NaCl 
and 25°C as parameters. 
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Furthermore, the design of the probe is optimized on the free energy gained from the displacement assay 
(Gdisp) and is calculated as: 
∆𝐺𝑑𝑖𝑠𝑝 = ∆𝐺ℎ𝑦𝑏∗𝑄/𝑇𝑎𝑟 −∆𝐺ℎ𝑦𝑏∗𝑄𝐹         Equation 1 
 
where Ghyb*Q/Tar and Ghyb*QF are respectively the free energy of hybridization of the duplex formed 
by the Q*/Target and Q*/F* strands. Probes are optimized in order to have favourable Gdisp to enhance 
the target displacement. 
The performance of the probe has been prior tested in solution. To obtain this information, the strands 
are labelled with a fluorophore and a quencher as reported in table 1. In this case, the displacement event 
is associated to a fluorescence recovery after quenching (TURN-ON mechanism Figure 8). Kinetics of 
hybridizations have been performed in solution mixing QF*probe with equimolar or 10-fold excess of 
target. As showed in Figure 2 the kinetics of hybridization depends on the target concentration added and 
the maximum recovery of fluorescence, due to complete target displacement, is achieved in 3-6 hours 
when the equimolar or excess of target is added into the solution. 
 
Figure 2 QF* probe/miR-143-3p kinetic of hybridizations 
 
The binding curve is obtained by plotting the fraction of bound QF* probe (alpha) versus quencher 
(Q*) concentration (Figure 3 A). Assuming an independent and equivalent sites model, the curve fitting 
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provides the binding constant (kb) and stoichiometry. The data confirms that the strands association is 
very high kb about 1.6*1010M-1 and 1:1 ratio stoichiometry. 
 
The melting profile is fully reversible at 50nM (Figure 3inset) and no significant hysteresis is observed 
between heating or cooling scans. The melting temperature is 47°C as predicted by OligoAnalyzer 
(Figure 3B; Table 1). 
 
 
Figure 4 Mechanism of target detection used to analyse the probe in solution and in bulk 
Figure 3 A)Fluorescence quenching titration to calculate kb of the probe. The stoichiometric ratio was determined by the intersection point 
of two straight lines extended, respectively, from the initial linear part and the plateau part of the titration curve. B) Melting profile, in the 
inset QF*probe annealing and melting curve  
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Bulk studies are carried out to optimize the probe density and to estimate the better PEGDA 
concentration capable to promote the free diffusion of oligonucleotides within the polymer network. 
These analyses confirm that the best analytical results are achieved using 1 μM of immobilized Tail and 
polymer concentration comprises between 10-15% of PEGDA. In particular, with the same amount of 
immobilized tails, the bulk with the highest concentration of PEGDA (narrower mesh size) allows a slow 
diffusion of *Qb strand and inefficient hybridization, as proved by the quick recovery of fluorescence 
following the quenching and the washing step (Figure 5). This event is ascribable to crowded 
environment into the bulk that obstacle the arrangement of a stable hybridization between the probe 
strands. By the contrast, in PEGDA 10%, the network is sufficiently wide to permit the formation of a 
stable complex between oligonucleotide strands, so that quenching is stable even after several washes. 
Increasing both probe density and polymer concentration, the hybridization kinetics, the quenching 
efficiency (Figure 6) and target detection (Figure 7) dramatically decrease due to the crowding effects 
and the hindered diffusion. This conclusion is also supported by additional studies made in our group. In 
particular, by swelling analysis and nuclear magnetic resonance (NMR) has been proved that increasing 
the PEGDA concentration the polymer mesh size decreases and diffusion is hindered (data not show). 
To sum up, these results obtained in bulk have allowed to set the best ratio between polymer and probe 
concentration in order to scale-down in microfluidics. 
 
Figure 5 Quenching of fluorescence *QFb in PEGDA 10% (A) and 20% (B). Each step was collected after 3 days of incubation. 
 
 
 
B A 
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Figure 6 Kinetic of quenching in PEGDA 10%-15%-20% with several oligonucleotides concentrations: (a) F* 1μM- Q* 1x; (b) F* 1μM- 
Q* 5x; (c) F* 5μM-Q* 1x; (d) F* 5μM- Q* 5x. 
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Figure 7 Bulk displacement efficiency 
 
In Figure 8 is showed each single step of 3D hydrogel microparticles detection mechanism. In 3D-
hydrogel microparticles, the target recognition is based on a double strand displacement assay integrating 
the probe sequence into the polymer network. However, in microparticles the target is quantified 
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measuring the depletion of fluorescence (TURN-OFF mechanism) (Figure 8B) instead of a recovery as 
already described. This is necessary, because of the UV- polymerization reaction in microfluidic induces 
a dramatically decrease of the reporter dye ATTO647N fluorescence. For this reason, in order to avoid 
mistake in target quantification, in 3D-hydrogel based assay the double strand probe consists of a short 
naked methacrylate DNA-Tail (T-DNA, 12 nt) covalently bound into the polymer networks during the 
polymerization and a longer partially complementary fluorescent DNA sequence (F-DNA, 21 nt), instead 
of *F- and Q*-probe respectively. In presence of target, the F-DNA strand hybridizes with it moving in 
the solution, with a consequent fluorescence decrease into the hydrogel.  
 
 
Figure 8 Target detection mechanism in 3D-hydrogel microparticles 
 
 
3.2. Three-dimensional hydrogel microparticles synthesis 
In Figure 9 A is showed an overview of the set-up used for the synthesis of 3Dhydrogel microparticles 
by microfluidics. The synthesis of hydrogels microparticles is performed using a T-junction microfluidic 
device (Figure 10 A-B). The LMO is injected as continuous phase, while the homogeneous water solution 
of PEGDA, methacrylate probes and photoinitiator is injected as dispersed phase.  
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Microfluidic parameters have been investigated and it has been found that a stable flow-rate regime is 
obtained when LMO flow rate (Qc) is between 6 and 10 μL/min and Capillary number (Ca) is in a limited 
range 0.05 ∼ 0.20. In this condition the polymer phase is broken into a stable emulsion with sizes in the 
range of 46 to 110 μm (Figure 10 B). The droplets are then cross-linked by UV free radical 
polymerization reaction out of the chip (Figure 9 B). The reaction involves three basic steps. Firstly, in 
the initiation reaction step, darocur free radical is formed under UV light. Then, during the propagation 
step, the free radical comes into contact with the end of a PEGDA molecule and reacts with the carbon-
carbon double bond in the acrylate functional group. This step produces a second free radical species, 
Microfluidic device 
UV 
1 
 2 
Figure 9 A) Schematic representation of microfluidic synthesis set-up for microparticles production; UV free radical photopolymerization 
between PEGDA and methacrylate oligonucleotide 
B A 
Figure 10 A) Geometry and size of the Dolomite chip; B)Droplet generation by microfluidic T-junction device 
B A 
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which can go on to react with more PEGDA polymers and/or methacrylate oligonucleotide species, 
propagating the crosslink until termination process occurs.  
Morphological analysis confirms that microparticles are monodisperse and spherical, with a diameter 
of about 80 μm (Figure 11 A-B). Moreover, microparticles are homogeneously functionalized into the 
whole 3D polymer as is showed in the images collected by CLSM, after hybridization step with the 
complementary fluorescent strand (Figure 13 B-II).
 
 
Microparticles swelling characterization proves that increasing the concentration of monomer the 
swelling ratio (Q) decreases from 11.42 to 4.87, the molecular weight (Mc) diminishes from 338 to 283 
Da, while the mesh size(ξ) in the range of 2.55-1.77 nm is achieved. Diffusion studies on hydrogels 
microparticles have been carried out to simulate the behaviour and diffusion of biological molecules. In 
particular, here are showed the diffusion analysis of the target miR-143-3p and the proteins BSA, 
following the fluorescence intensity changes by CLSM images. In Figure 12 A is reported a plot profile 
of fluorescence intensities of the oligonucleotide. Probe diffusion is not hindered (Da>>1) and in few 
minutes the process is completed. The diffusion behaviour of probes is measured as ratio between 
fluorescence intensity (I) and maximum fluorescence reached in the microparticles (IMAX) versus time 
and fitting following Equation 2.  
I
IMAX
= 1− 𝑒−
𝑡
𝜏            Equation 2 
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Figure 11 A)Size distribution of functionalized microparticles (PEGDA 10%, 15%, 20%) w/v); B) Optical image of monodisperse 
microparticles; Swelling parameters ( Q, ξ, Mc) for different polymer concentrations 
B A C 
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where τ is the extrapolated value that represents the time required to achieve 67% of maximum intensity. 
In such a way, τ is calculated from the curves and corresponds to 5.7 ± 0.3 min for the oligonucleotide 
and 28.4 ± 1.0 for the BSA. Consequently, the oligonucleotide diffusion coefficient (D) into the hydrogel 
microparticle is 26.6·10-8 cm2/s. The value measured is comparable to that observed for free 
oligonucleotide in solution (115·10−8 cm2/s for size of 23mer59). This result confirms that the 3D hydrogel 
structure is comparable to free solution and works as molecular filter hindering the diffusion of bigger 
molecules like proteins.
 
 
3.3. Assay set-up and human serum analysis 
The assay is easily performed adding about 300 3D-hydrogel microparticles to the sample and incubating 
until equilibrium is reached. Then fluorescence depletion is measured and the target concentration is 
quantified based on the calibration curve. 
 Analysing the fluorescence images collected during the various preparation steps results that 3D-
functionalized hydrogels have very low fluorescence background after microfluidic synthesis (Figure 
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Figure 12 A) Plot profile of fluorescence intensity of Oligonucleotide diffusion in microparticles.    
B) Time lapse of fluorescence intensity (I/Imax) of miR-143-3p and BSA. All values reported show a standard deviation of 10%. 
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133 A-B I). Moreover, the fluorescent signal significant increases after incubation with F-DNA (Figure 
133-B II), this confirms that hybridization has occurred. 
 When the target is spiked into the solution, it quickly diffuses into the 3D hydrogel network and driven 
by the favourable G of displacement, it hybridizes with the complementary F-DNA strand diffusing out 
of the hydrogel with consequent decrease of the hydrogel fluorescence (Figure 13A-B III). Furthermore, 
3D-hydrogel microparticles can be directly added to the human sample without any previous 
oligonucleotide purification or amplification. The target is easily quantified reading the fluorescence 
depletion associated with the displacement event and as shown in Figure 13A-B IV the displacement in 
human serum is comparable to that in hybridization buffer.
 
3.4. Assay sensitivity and specificity 
Under the optimized experimental conditions, the analytical performances of the proposed 3D-hydrogel 
microparticles are showed in Figure 14. The depletion of fluorescence in response to the miR-143-3p 
Figure 13:(a)Fluorescence intensity measured during the hydrogel based assay setup and (b) the corresponding CLSM 
images. In particular, the figure shows the fundamental steps involved in the target detection: (I) after the synthesis of 
functionalized hydrogel; (II) when the fluorescent DNA strand was added; (III) in presence of the target in hybridization 
buffer and (IV) in human serum. 
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concentration is shown in Figure 14A. For each target concentration images are collected (Figure 14C) 
and analysed. The fluorescence signal decreases gradually increasing the target concentration and the 
efficient working range is comprised between 10-6 to 10-12 M. Complete displacement, about 
93.1±0.76%, is achieved testing 2 μM of mir-143-3p. Decreasing the target concentration to 500 pM, we 
reach 73±5.09% of displacement, which decreases until 3.6±1.08% at the lower concentration tested 
(Figure 14C). Moreover, the limit of detection (LOD) and limit of quantification (LOQ) are calculated 
and their values are respectively 30 pM and 91 pM. (Table 3). 
 
Table 3 Data analysis for 3D-hydrogel microparticles assay 
 SE SD R- sq Slope 
LOD 
 (pM) 
LOQ 
 (pM) 
3D-hydogel 
microparticle 
3.09598 5.3623 0.9987 0.5868 30.156 91.382 
 
Figure 14 (A) MiR143-3p capture efficiency by Hydrogel beads assay and (B) corresponding fluorescence intensity turn-off  (C) Images 
collected by CLSM for the target concentration analysed (Scale bars: 100 μm). 
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Additionally, specificity studies have been carried out on the 3D-hydrogels. To investigate the assay 
specificity, 3D-hydrogel microparticles are put in contact with 500nM of miR-21, then images are 
collected (Figure 15B) and analysed. From the fluorescence intensity measurements (Figure 15A) result 
that in presence of high concentration of non-specific microRNA (Table 1) a slight fluorescence intensity 
decrease is measured when compared with the control. Nevertheless, 500nM of miR-143-3p achieve a 
much stronger response compared to the blank. Furthermore, any interference in target displacement is 
observed when combined solutions of miR-143-3p/miR21 500nM (1:1) are tested. This suggests that the 
designed probe has good selectivity toward miR-143-3p and the hydrogel microparticles are capable to 
detect the target even in presence of crowded oligonucleotide solutions.
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4. CONCLUSION 
The purpose of this study is to combine the enhanced properties of 3D engineered hydrogel material 
with the necessity of the health field. In particular, we focused on the design of an assay for microRNA 
detection based on double strand displacement assay confined into a small hydrogel particle volume.  
The parameters affecting the sensitivity and the diffusion have been studied both in solution and bulk, 
and the best ratio between probe and polymer concentration has been selected. Based on this 
consideration we have synthesized 3-D hydrogel microparticles with PEGDA 15% and T-DNA 1μM in 
microfluidics.  
Tests in complex matrix as in human serum, fulfilled with CLSM, have demonstrated the capability of 
our microparticles to be used as a molecular filter allowing the target diffusion and excluding the majority 
of big molecules. Indeed, the detection system resulted to be very efficient with a displacement 
percentage of ⁓90%, comparable to that observed in buffer solution. The assay has also proved good 
sensitivity with LOD of 30 pM and good specificity. 
The assay has shown several advantages compared to conventional techniques. Indeed, hydrogels are 
synthetized and functionalized in microfluidics in higher concentration reducing time and cost of 
production. They might be directly mixed into the human sample without any previous oligonucleotide 
purification or amplification resulting time saving and easy to manage. Furthermore, the target is easily 
quantified reading the fluorescence depletion associated with the displacement event avoiding complex 
analysis interpretations. 
Therefore, 3D-hydrogel microparticles-based assay represents a highly promising method for 
developing low cost, sensitive routine test and non-invasive analytical tests.  
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CHAPTER 6 
CONCLUSIONS AND FUTURE PERSPECTIVES 
Throughout this thesis, we have developed and tested a hydrogel microparticles platform, that has 
proved to be attractive for biosensing applications.  
In particular, we have demonstrated that superior materials and optimized oligonucleotide probe design 
are successfully combined to produce engineered hydrogel microparticles for circulating biomarker 
detection. 
Compared to gold standard technologies, our hydrogels avoid all the sample preliminary manipulation 
steps as the purification, extraction or amplification, often cause of quantification errors in these assays. 
In addition, the limit of detection and the specificity are improved compared to the current amplification-
free assay and the time of analysis are reduced, especially for molecular beacons-microgels assays.  
Therefore, PEG-based hydrogels represent ideal materials for this purpose combining broad range of 
molecular weight, chemical functionalities and biocompatibility. Microparticles have been synthetized 
with different chemical strategy both in batch and microfluidics and their structural characteristics have 
been tuned for the purpose.  
The hydrogel solution-like property enhances both the thermodynamic association constants and the 
kinetics (association rate kon) for oligonucleotides, while its anti-fouling property imparts selectivity in 
biological fluids. Moreover, the fluorescent signal confinement of the specific probe into small volume 
allows to directly detect target with improved sensitivity compared to the common assay.  
The design of specific oligonucleotide probe, in addition, consents to reach appealing sensitivity, single 
nucleotide specificity and rapid time of analysis. Moreover, all the hydrogels used in this thesis share the 
capability of work directly in human fluids due to the Poly(ethylene)glycol antifouling capability. 
In this thesis we have highlighted the potentiality of hydrogel particles technologies and presented some 
proof of principle applications. 
In particular, in chapter 2 we have designed a heterogeneous assay by using PEG microgels armed with 
short fluorescent DNA double strand probes for the specific detection of viral microRNA biomarker by 
toehold-mediated strand displacement assay.  
The assay is specific toward the selected target and the toehold mediated strand assay has improved the 
kinetics of recovery compared to perfect double strand probe.  
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The target has been detected with scalable sensitivity down to 150 aM and over a wide dynamic range 
(from nM to aM). Moreover, we have proved that microgel assay can be finely measured by the means 
of common laboratory equipment, as fluorimeter and flow cytometer, without loss in sensitivity.  
Additionally, we have proved that our technology is very stable over a long period of storage, overcoming 
one of the main limitations that until now have delayed the marketing of hydrogel bioassay kits.  
In chapter 3 we have synthetized PEG-microgels functionalized with molecular beacons for the 
detection of miR-21. Molecular beacons have been immobilized into the hydrogel polymer network 
tuning the probe density and the length of the probe. Studies have proved that fluorescence background 
is reduced when molecular beacons are immobilized into solution-like environments as those generated 
in PEG hydrogel matrix, improving both the sensitivity and the specificity of the assay. 
We have optimized the molecular beacon probe density and the concentration of microgels achieving 
down to fM sensitivity. The assay is specific toward single mutated target and the miR-21 is detected in 
1 hour using only 20µL of sample. The solution-like environment within the microgel is capable to 
protect molecular beacons from the interfering proteins of the serum, indeed, the target detection results 
similar to those observed in PBS buffer. 
In chapter 4 the basis to detect long oligonucleotide sequences by microgel-based assay has been 
established. Microgels are functionalized with double strand or molecular beacon probes, specifically 
designed and tested versus two sequence with 70% of similarity. 
Both probes have shown higher specificity in presence of the similar target free in solution and 
immobilized on the particle. The sensitivity is measured in pM order for ds-microgels, while mb-
microgels have reached limit of detection down to pM. The assay time is additionally reduced for mb-
microgels achieving complete target hybridization in 100 min.  
The combination of the customized probes with the solution-like property of the hydrogel material and 
its capability to concentrate the fluorescence signal have allowed to develop sensitive and fast microgel 
assay for long oligonucleotide target. 
In chapter 5 3D engineered hydrogels for oligonucleotide detection have been developed by 
microfluidics. In particular, we have focused on the design of an assay for microRNA detection based 
on double strand displacement assay associated with fluorescence depletion event. The parameters 
affecting the sensitivity and the diffusion have been studied both in solution and bulk, and the best ratio 
between probe and polymer concentration has been selected. 
The assay has proved good specificity and sensitivity with limit of detection of 30 pM. Tests in human 
serum have confirmed the capability of our microparticles to work as molecular filter allowing the target 
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diffusion and excluding interfering molecules. Moreover, the assay has shown several advantages 
compared to conventional techniques. Indeed, hydrogels are synthetized and functionalized in 
microfluidic in higher concentration reducing time and cost of production. They might be directly mixed 
into the human sample without any previous oligonucleotide purification or amplification resulting time 
saving and easy to manage, avoiding complex analysis interpretations. 
 
This hydrogel based technology promises to be useful for liquid biopsy and point-of-care application 
widening the range of application not only in poor clinical settings. Furthermore, additional studies on 
real human samples and comparative analysis with gold standard techniques are still on-going to further 
validate the application in clinical routine of the hydrogel platform for oligonucleotide biomarkers 
detection. 
  
 
Table 1 Technology properties of the hydrogel microparticles proposed in the thesis. 
Technology Probe Target LOD Time Sample 
volume 
Complex 
fluid 
Amplification 
PEG-
core/shell 
microgels 
Double-
strand 
probe 
hcmv-
miR-US4-
5p 
150aM 5 h 500µL Yes No 
PEG-
core/shell 
microgels 
Molecular 
beacon 
hsa-miR-
21 
10fM 1 h 20 µL Yes No 
PEG-
core/shell 
microgels 
Double-
strand 
probe 
P1 
P2 
530pM 
813pM 
2-5 h 500 µL Yes No 
PEG-
core/shell 
microgels 
Molecular 
beacon 
P1 
P2 
1.32pM 
1.06pM 
1-2 h 20 µL Yes No 
Microfluidics 
PEG-particles 
Double 
strand 
probe 
hsa-miR-
143-3p 
30pM >5 h 500 µL Yes No 
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In the future, the possibility to detect also circulating DNA represents an appealing objective. 
Therefore, the final goal of this project is the production of a microfluidic platform for in vitro, 
direct measurement of oligonucleotides circulating in biological fluids.  
In particular, we foresee the possibility to accomplish a miniaturized system to directly analyze 
low volume of biological sample. Indeed, our major challenge is pointed toward the production 
of an integrated device for liquid biopsy application and point-of-care (POC) diagnostics.  
 
 
 
 
